PuriActives® RutaSuc™

PuriActives®RutaSuc™ 芸珀因™

INCI name: RUTINYL SUCCINATE

01 · MARKET CONTEXT · 市场背景

Skin under oxidative stress — a new formulation brief

Daily environmental exposure keeps skin under chronic oxidative stress — and this has rewritten what brands expect from an active ingredient.

01Environmental load is daily exposure.UV, ozone, and particulate pollutants drive reactive oxygen species (ROS) generation in skin, linking environmental stress to visible dullness, redness, and premature aging signs.

02Sensitivity and visible redness have gone mainstream.Sensitive-skin positioning has moved from niche dermo-skincare into the core skincare development agenda.

03Well-known molecules win trust.Brands prefer actives with a name, a structure, and published literature over anonymous antioxidant blends.

04Multifunctionality wins formulas.A well-characterized molecule supporting multiple defensible claims significantly reduces formulation cost and complexity.

The biological map of oxidative stress is well established — the bottleneck is getting a long-validated defense molecule into an elegant formula. The opportunity is not “yet another antioxidant,” but bringing a proven flavonoid molecule into real formulations.

Sources: Rinnerthaler et al., Oxid. Med. Cell. Longev., 2015; Ganeshpurkar & Saluja, Saudi Pharm. J., 2017.

02 · THE MOLECULE · 认识分子

Rutin — one of the best-known bioactive flavonoids

Rutin — quercetin-3-O-rutinoside

C27H30O16 · CAS 153-18-4 · flavonol glycoside

A flavonol glycoside built from the quercetin aglycone and the rutinose disaccharide. Its catechol B-ring and conjugated chromone core are among the most thoroughly studied radical-scavenging pharmacophores in natural-product science.

Abundant natural sourcing — concentrated in Sophora japonica flower buds, buckwheat, citrus, and asparagus; a molecule consumers already ingest in their daily diet.

The “vitamin P” heritage — in 1936 Szent-Györgyi linked citrus flavonoids, including rutin, to capillary resistance (Nature), opening nearly a century of microvascular research.

Deep biological evidence — radical scavenging, metal-ion chelation, and modulation of inflammation-related pathways documented across hundreds of peer-reviewed studies and reviews.

Clear regulatory identity — the EU CosIng inventory lists RUTIN with antioxidant, skin-conditioning, and hair-conditioning functions: a recognized cosmetic identity, not an unfamiliar newcomer.

Sources: Rusznyák & Szent-Györgyi, Nature, 1936, 138, 27; Afanas’ev et al., Biochem. Pharmacol., 1989, 38, 1763–1769; Gullón et al., Trends Food Sci. Technol., 2017, 67, 220–235; European Commission CosIng inventory.

03 · THE FORMULATION PROBLEM · 配方挑战

Native rutin resists formulation

0.125 g/L

Rutin water solubility at 25 °C — roughly 8 liters of water per gram of active.

log P +0.85

n-Octanol/water partition coefficient (pH 7.4): a crystalline glycoside with neither hydrophilic nor lipophilic affinity.

Rutin’s planar polyphenolic backbone stacks into stable crystal lattices; its glycosidic hydroxyls are locked in intermolecular hydrogen bonds instead of hydration.

What this means at the bench

Precipitates in water-based systems — serums, toners, and gels cannot carry an effective dose.

Depends on solubilizers and co-solvents — extra surfactant or alcohol load, sacrificing skin feel and mildness.

Recrystallizes on shelf — haze, sediment, and active-content drift in finished products.

Excluded from modern formats — clear serums, cold-process manufacturing, and water-based scalp products are essentially off-limits.

The problem was never the biology — it is the physical form of the molecule.

Sources: Pedriali et al., Quim. Nova, 2008, 31, 2147–2151 (solubility, log P); Gullón et al., Trends Food Sci. Technol., 2017, 67, 220–235.

04 · THE SOLUTION · 解决方案

PuriActives® RutaSuc™ — rutin, made for water

RutaSuc™ is rutinyl succinate: succinate groups introduced onto rutin’s sugar moiety. The design logic is direct — keep the flavonoid pharmacophore, change the molecule’s relationship with water.

Ionizable carboxyls — up to six succinyl groups introduce hydrophilic carboxyls along the rutinose chain.

80–115× higher water solubility — from 0.125 g/L to 10–14.4 g/L, measured independently by two research groups.

A genuinely hydrophilic flavonoid — partition coefficient flips from log P +0.85 to −1.13, a complete reversal of polarity class.

Ready-to-use form — supplied as a 5% aqueous solution, added directly to the water phase with no solubilization step.

Rutinyl succinate: 14.4 g/L (Sachetto et al., 2022) and 10.0 g/L (Pedriali et al., 2008) — an 80–115× improvement over native rutin (0.125 g/L).

The same flavonoid core — a completely different formulation reality.

Sources: Pedriali et al., Quim. Nova, 2008, 31, 2147–2151; Sachetto et al., Front. Pharmacol., 2022, 13, 828269.

04 · THE SOLUTION · MOLECULAR ARCHITECTURE

Molecular architecture — succinylated sugars, intact core

A defined family of 1–6 substitution forms, centered on DS 2–3 (30.7% / 27.6%); the flavonoid aglycone fragment (m/z 303) is preserved across all forms.

Spectroscopically confirmed identity

· The characteristic flavonoid UV-Vis absorption bands remain at 271 / 352 nm after succinylation — the chromophore is unchanged.

· 1H / 13C-NMR confirms esterification occurs only at sugar hydroxyls; the aromatic 5-OH signal is intact.

· LC-MS: each succinyl unit adds 100 Da, exactly as expected.

Sources: Pedriali et al., 2008; Sachetto et al., 2022.

05 · MECHANISM · 作用机制

One molecule, four lines of defense

The mechanism framework integrates rutin pharmacology literature with experimental data on rutin succinate; pathway-level evidence is detailed in the following sections.

06 · EVIDENCE · 实证数据

Radical-trapping capacity, measured at the molecular level

Model: luminol/AAPH chemiluminescence (Total radical-trapping Antioxidant Parameter, TRAP), 0.2–1.0 µM, Tris buffer pH 9.0, 37 °C. Test items: rutin succinate (n = 3.03 ± 0.08), rutin (n = 3.53 ± 0.07), Trolox® reference (n = 2). All means differ significantly at the 0.05 level.

≈1.5× Trolox®

Antiradical capacity of rutinyl succinate relative to the standard water-soluble antioxidant reference

The succinate groups themselves help.At the assay pH, the deprotonated carboxyls carry negative charge and attract the cationic peroxyl radicals generated by AAPH thermolysis.

Retains 86% of rutin’s trapping power — in a water-compatible form.Despite an ~80-fold gain in hydrophilicity, each molecule still traps about three radicals.

Cosmetic relevance:verified scavenging of peroxyl-type radicals — precisely the radical class that drives oxidative lipid damage in skin.

Source: Pedriali et al., Quim. Nova, 2008, 31(8), 2147–2151. DOI: 10.1590/S0100-40422008000800039

06 · EVIDENCE · 实证数据

Membrane lipid protection in a biological matrix

Model: spontaneous oxidation of rat-brain homogenate membranes; malondialdehyde (MDA) quantified as the TBA adduct at 535 nm. Test items compared on an equimolar flavonoid-core basis. Result: despite extreme hydrophilicity (log P −1.13), rutinyl succinate still engages membrane lipids and inhibits peroxidation by 77.9% — only ~19% below native rutin on a flavonoid-core basis. Hydrophilicity did not cost the molecule its biological reach.

For skin, membrane lipid peroxidation is exactly where oxidative stress “becomes visible.”

Source: Pedriali et al., Quim. Nova, 2008, 31(8), 2147–2151. DOI: 10.1590/S0100-40422008000800039

06 · EVIDENCE · 实证数据

A flavonoid core built for inflammatory-stress pathways

Macrophage inflammatory-mediator modulation (rutin, mechanistic level).In LPS-stimulated macrophages, rutin down-regulates key inflammatory mediators such as TNF-α and COX-2-derived prostaglandins while raising the anti-inflammatory marker IL-10 — showing the flavonoid core is a modulator of inflammatory signaling, not merely a radical scavenger.

Pathway-level support (rutin, review level).Mechanistic reviews consistently place rutin upstream of NF-κB, COX-2, and iNOS — the very signaling axis that converts oxidative damage into redness, discomfort, and matrix degradation in stressed skin.

The pharmacophore performing these actions is fully preserved.Succinylation is confined to the sugar moiety; the catechol B-ring responsible for antioxidant and signaling interactions is untouched.

Direct confirmation on rutinyl succinate.Sachetto et al. showed the modified molecule retains rutin-like activity, including inhibition of protein disulfide isomerase (PDI) and interaction with plasma proteins — direct evidence that the flavonoid core still binds biological targets.

Evidence-grading note: direct rutinyl succinate data (Grade A) confirm activity retention; rutin mechanistic data (Grade B) serve as supporting evidence for core preservation. No independent RutaSuc™ inflammation study is claimed.

Cosmetic translation.Redness-prone, reactive skin is essentially skin living in an overactive “stress–inflammation” loop. An active that intercepts radicals before they reach this axis — with documented mediator modulation by its preserved core — directly answers the sensitive-skin brief.

Sources: Kauss et al., Arthritis Res. Ther., 2008, 10, R19; Ganeshpurkar & Saluja, Saudi Pharm. J., 2017, 25, 149–164; Sachetto et al., Front. Pharmacol., 2022, 13:828269

06 · EVIDENCE · 实证数据

The vitamin P heritage — made for redness-prone skin

1936

Rusznyák and Szent-Györgyi describe “vitamin P”: flavonoid extracts that restore capillary resistance — with rutin as the reference substance.

Ninety years of capillary research.Rutin and its semi-synthetic derivatives (troxerutin, rutin sulfates) are among the longest-studied flavonoid families in microvascular research — the scientific lineage behind the “P factor.”

Protein-target activity retained.Rutinyl succinate preserves rutin’s inhibition of protein disulfide isomerase (PDI) and its interactions with fibrinogen and albumin — direct evidence the molecule still binds the protein targets relevant to rutin’s vascular biology.

Why it matters topically.A water-compatible rutin can finally enter daily leave-on skincare — and visible redness and reactive tone are appearance concerns adjacent to microcirculation.

Cosmetic translation

· Visible redness — soothing care for reactive, redness-prone complexions

· Eye contour — where microcirculation shows most readily through thin skin

· Post-stress recovery — calming formats for after sun exposure and aesthetic procedures

· Even tone — daily defense for complexion uniformity

Positioning note: RutaSuc™ is a cosmetic active for appearance care. The microvascular literature on rutin-class molecules establishes mechanistic plausibility and scientific heritage — it does not constitute any therapeutic claim for finished cosmetic products.

Sources: Rusznyák & Szent-Györgyi, Nature, 1936, 138, 27; Sachetto et al., Front. Pharmacol., 2022, 13:828269; Jasuja et al., J. Clin. Invest., 2012, 122, 2104–2113

06 · EVIDENCE · 实证数据

Photo-stress: a chromophore that still “sees” UV

Schematic curve reconstructed from the published absorption peaks of rutinyl succinate (λmax 271 and 352 nm, UV-Vis, Bands II and I of the flavonol chromophore). Peak positions are measured data; the curve shape is illustrative, not a measured spectrum.

The chromophore survives modification.Succinylation leaves the conjugated flavonol system unchanged — the molecule’s characteristic UVA/UVB absorption is essentially intact.

A second line of defense.RutaSuc™ is not a UV filter and makes no SPF claim. Its role is handling the oxidative chemistry UV triggers downstream — quenching radicals and protecting lipids.

Formulation logic.An ideal partner for daily-defense and after-sun concepts — complementary to sunscreen actives, never a replacement.

Sources: Pedriali et al., Quim. Nova, 2008, 31(8), 2147–2151; Sachetto et al., Front. Pharmacol., 2022, 13:828269

06 · EVIDENCE · 实证数据

Scalp & hair: a water-compatible flavonoid for leave-on scalp care

The scalp is an oxidative-stress hotspot.Sebum-rich, UV-exposed, and densely folliculated, the scalp faces a unique oxidative burden; oxidative stress at the follicle is linked to scalp discomfort and hair-quality issues (Trüeb, 2009).

Hair-care regulatory basis.The EU CosIng database lists rutin with antioxidant, skin-conditioning, and hair-conditioning functions — an established regulatory precedent for flavonoids in hair and scalp products.

Built for the format.Scalp care is dominated by watery leave-on formats — tonics, essences, sprays — precisely the systems native rutin could never enter. RutaSuc™ is supplied as a 5% aqueous solution, ready to add directly.

Verified activity, the relevant radical class.TRAP-verified peroxyl-radical trapping maps directly onto the lipid-peroxidation chemistry of sebum oxidation at the scalp surface.

Concept directions

· Soothing scalp tonic — daily leave-on antioxidant defense for sensitive, tight scalps

· Post-color/perm calming spray — oxidative-stress care after chemical services

· Pre-wash essence — concentrated flavonoid delivery in a water-based essence texture

· Anti-pollution scalp mist — an urban-defense positioning backed by a TRAP-verified active

Sources: Trüeb, Int. J. Trichology, 2009, 1(1), 6–14; EU CosIng database, RUTIN (CAS 153-18-4); Pedriali et al., Quim. Nova, 2008

07 · FORMULATION SCIENCE · 配方科学

Formulation science: a ready-to-use aqueous active

Supplied-form property RutaSuc™ specification
Form 5% aqueous solution of rutinyl succinate
Appearance Clear to slightly opalescent liquid, pale yellow to amber
pH 3.5 – 5.5
Density (20 °C) 0.990 – 1.050 g/mL
Refractive index 1.360 – 1.420
Dry residue 5 – 20%
Solubility Miscible with water, glycerin, propylene glycol, and ethanol (slight opalescence)
Preservative system Sodium benzoate · potassium sorbate · tetrasodium EDTA
Shelf life 24 months, protected from light

At the bench

Addition — add to the water phase at any stage; no heating, no solubilizers, no neutralization step.

Suitable systems — emulsions, gels, toners, serums, sprays, and hydroalcoholic systems.

Handling notes — avoid strong oxidizers and prolonged exposure above 35 °C; store protected from light.

Settling behavior — slight haze may appear on standing; shake before use. Normal for a high-load botanical-derived active.

Because RutaSuc™ is supplied pre-dissolved, the classic “rutin won’t go in” workflow — solvent hunting, heated processing, crystallization monitoring — disappears entirely.

Source: PuriPharm Co. Ltd. product documentation, PuriActives® RutaSuc™ supplied-form data.

08 · APPLICATIONS · 应用方向

Six fields, one active

Sensitive & redness-prone skinThe vitamin P heritage plus verified radical interception — soothing serums, calming essences, post-procedure care.

Antioxidant daily defenseUrban day creams, anti-pollution mists, and ampoule drops built around TRAP-verified, 1.5×-Trolox radical trapping.

Healthy agingThe matrix-stress narrative — lipid protection at the MDA level, plus mechanistic support against the oxidative signals that drive MMPs.

Tone & radianceDullness is oxidation made visible; tone-evening and brightening serums gain a credible mechanistic story.

Eye careThin skin, visible microcirculation, constant light exposure — the most natural home for the microvascular heritage.

Scalp careWater-based leave-on tonics, sprays, and essences — formats that were structurally off-limits to native rutin.

Application fields are derived from the evidence grading summarized in the Evidence Map section; no clinical efficacy claims are made for finished products.

08 · APPLICATIONS · 应用方向

Bench concept framework

Urban antioxidant serum Redness-soothing essence Scalp defense tonic
Format Light O/W serum or water-based ampoule drops Watery essence / gel-serum Leave-on scalp tonic or spray
RutaSuc™ role Lead antioxidant: TRAP-verified radical trapping and membrane lipid protection Soothing defense active: vitamin P heritage and preserved anti-inflammatory core Scalp antioxidant: targeting sebum peroxidation and follicular oxidative stress
Addition Water phase, room temperature, no solubilizers Water phase, room temperature, no solubilizers Direct addition to water-based base
pH target 5.0 – 5.5, within the 3.5 – 5.5 specification window 5.0 – 5.5, skin-identical positioning 4.5 – 5.5, scalp-friendly range
Positioning line “Urban-grade antioxidant defense, evidenced at 1.5× Trolox” “Flavonoid soothing for reactive, redness-prone skin” “Daily antioxidant care for the scalp”

Illustrative development framework, not finished formulas. Use-level guidance, stability screening, and prototype support are available from PuriPharm Co. Ltd. technical service.

09 · POSITIONING · 市场定位

Where RutaSuc™ sits on the active-ingredient map

Native rutin owns the science but fails the bench.Decades of literature and near-universal recognition — trapped in a molecule that cannot enter water-based formulas.

Synthetic antioxidants pass the bench but have no story.Benchmark water-soluble antioxidants formulate easily, yet offer no flavonoid heritage, no microvascular narrative, no recognizable natural lineage.

RutaSuc™ occupies the intersection — delivering rutin’s documented biology in a formulators-friendly form, a position no single benchmark can hold alone.

Qualitative internal benchmark (PuriPharm Co. Ltd., 2026). Scores 0–5; no third-party brand is named or implied.

10 · EVIDENCE MAP · 证据地图

Evidence tier Description Sources
A Direct: rutinyl succinate Water solubility 0.125 → 10–14.4 g/L (~80–115×); log P +0.85 → −1.13; DS 1–6 distribution confirmed by LC-MS and NMR Pedriali et al., 2008; Sachetto et al., 2022
A Direct: rutinyl succinate TRAP radical trapping 3.03 ± 0.08 per molecule (~1.5× Trolox reference); retains 86% of rutin’s trapping capacity Pedriali et al., 2008
A Direct: rutinyl succinate Membrane lipid peroxidation inhibition 77.9% (vs rutin 97.2%, equimolar flavonoid-core basis); IC50 19.51 µM; CUPRAC and PDI-inhibition activity retained Pedriali et al., 2008; Sachetto et al., 2022
B Mechanistic: rutin core Catechol pharmacophore preserved; rutin down-regulates macrophage TNF-α / COX-2 mediators, chelates redox-active metals, supports capillary resistance (vitamin P) Kauss et al., 2008; Afanas’ev et al., 1989; Rusznyák & Szent-Györgyi, 1936
B Mechanistic: rutin core Regulatory precedent: EU CosIng lists rutin as antioxidant, skin-conditioning, and hair-conditioning ingredient EU CosIng database, CAS 153-18-4
C Application logic Scalp oxidative stress, photo-oxidative burden, and redness-prone skin as cosmetic targets for a water-compatible flavonoid Trüeb, 2009; Rinnerthaler et al., 2015

Transparency note: Grade A data were measured on rutinyl succinate itself; Grade B is native-rutin data, applicable because the pharmacophore is preserved; Grade C is cosmetic application logic. Rutin literature is never presented as RutaSuc™ product data.

11 · WHY RUTASUC™ · 核心总结

Why RutaSuc™

01 Science derived from rutin.Built on one of the most thoroughly studied flavonoids in cosmetic and biomedical literature — the vitamin P heritage, CosIng-listed functions, ninety years of mechanistic research.

02 Molecular-level optimization.Succinylation of the sugar hydroxyls turns a practically insoluble flavonoid (0.125 g/L) into a water-compatible active (10–14.4 g/L) — an ~80–115× improvement — without touching the catechol pharmacophore.

03 Verified radical defense.~1.5× Trolox by TRAP and 77.9% membrane lipid peroxidation inhibition — both measured on the rutinyl succinate molecule itself in peer-reviewed models.

04 Ready for formulators.Supplied as a preserved 5% aqueous solution — water-phase addition, no heating, no solubilizers; suitable for emulsions, gels, toners, and sprays.

05 Broad application breadth.Six cosmetic fields — sensitive skin, antioxidant defense, healthy aging, tone, eye care, scalp — from a single well-documented active.

12 · CLOSING · 结语

Turning classic flavonoid science into a modern cosmetic active platform.

01The biology was never the problem.Rutin’s pharmacophore is fully preserved in RutaSuc™ — radical trapping, membrane lipid protection, and protein-target binding all survived succinylation.

02The form was the problem.An ~80–115× solubility gain and a ready-to-use 5% aqueous form remove every barrier between rutin science and modern water-based formulation.

03The evidence stands up to audit.Direct rutinyl succinate data, rutin mechanistic literature, and application logic are clearly tiered — nothing borrowed, nothing overstated.

PuriPharm Co. Ltd. · PuriActives® Cosmetic Actives

Technical documentation, samples, and formulation support available on request.

APPENDIX · 附录

Selected references

1. Pedriali, C. A.; et al. Synthesis of a water-soluble rutin derivative as an antiradical agent. Quim. Nova, 2008, 31(8), 2147–2151. DOI: 10.1590/S0100-40422008000800039

2. Sachetto, A. T. A.; et al. The bioflavonoids rutin and rutin succinate: chemical characterization and biological evaluation. Front. Pharmacol., 2022, 13, 828269. DOI: 10.3389/fphar.2022.828269

3. Rusznyák, S.; Szent-Györgyi, A. Vitamin P: flavonols as vitamins. Nature, 1936, 138, 27.

4. Li, K.; et al. Advances in structural modification and biological activities of rutin. Chinese Traditional and Herbal Drugs, 2021, 52(20), 6413–6424. DOI: 10.7501/j.issn.0253-2670.2021.20.032

5. Gullón, B.; et al. Rutin: a review on extraction, identification and purification methods, biological activities and approaches to enhance its bioavailability. Trends Food Sci. Technol., 2017, 67, 220–235. DOI: 10.1016/j.tifs.2017.07.008

6. Ganeshpurkar, A.; Saluja, A. K. The pharmacological potential of rutin. Saudi Pharm. J., 2017, 25(2), 149–164. DOI: 10.1016/j.jsps.2016.04.025

7. Kauss, T.; et al. Modulatory effect of rutin on pro- and anti-inflammatory mediators in activated macrophages. Arthritis Res. Ther., 2008, 10, R19. DOI: 10.1186/ar2372

8. Afanas’ev, I. B.; et al. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem. Pharmacol., 1989, 38(11), 1763–1769.

9. Jasuja, R.; et al. Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents (rutin-class flavonoids). J. Clin. Invest., 2012, 122(6), 2104–2113. DOI: 10.1172/JCI61228

10. Alluis, B.; et al. Water-soluble rutin derivatives: synthesis and antioxidant properties. Helv. Chim. Acta, 2000, 83(2), 428–443.

11. Rinnerthaler, M.; et al. Oxidative stress in aging human skin. Oxid. Med. Cell. Longev., 2015, 2015, 586398. DOI: 10.1155/2015/586398

12. Trüeb, R. M. Oxidative stress in ageing of hair. Int. J. Trichology, 2009, 1(1), 6–14.

13. Jovanovic, S. V.; et al. Flavonoids as antioxidants. J. Am. Chem. Soc., 1994, 116(11), 4846–4851.

14. European Commission. CosIng — Cosmetic Ingredients Database: RUTIN (CAS 153-18-4); RUTINYL SUCCINATE (CAS 267006-02-0). Commission Decision 2006/257/EC and updates.

All sources are publicly published and verifiable. Product supplied-form data: PuriPharm Co. Ltd. internal documentation.

PuriActives® S-Glucan

PuriActives® S-Glucan

Sulfated polysaccharide technology for sensitive and stressed skin

01 · THE FORMULATION CHALLENGE · THE CHALLENGE

Efficacy keeps advancing — tolerability has not kept up

High-efficacy actives — retinoids, exfoliating acids, vitamin C — remain the strongest drivers of visible skincare results, and are also among the most common triggers of stinging, visible redness and barrier stress. For a growing number of consumers, the bottleneck of a skincare routine is no longer efficacy, but how much stress the skin can withstand.

Everyday stress scenarios that amplify skin reactivity

● Retinoid adjustment periods and over-exfoliation

● Acid peels and high-strength vitamin C routines

● UV, pollution and climate-change stress

● Aesthetic procedures — laser, peels, microneedling

● Shaving and daily mechanical friction

60–70%of women self-report some degree of sensitive skin; 50–60% of men do as wellFarage MA, Cosmetics, 2019 44.6%of American adults self-report “sensitive” or “very sensitive” skin in a representative national surveyMisery L et al., Int J Dermatol, 2011

Formulation insight: every high-efficacy system now needs a built-in tolerability strategy — starting at the ingredient level.

02 · MARKET CONTEXT · THE MARKET

Sensitive skin & barrier repair: a structural growth engine

$80.3BDermocosmetic skincare market size in 2031, up from $50.3B in 2025 — an 8.1% CAGR; dermatology-backed skincare is going mainstreamMordor Intelligence, 2026 edition +9.9%Forecast CAGR of the sensitive-skin segment (2026–2031) — the fastest-growing skin-need trackMordor Intelligence, 2026 edition $12.6BRepairing skincare market size in 2036, growing from $6.9B in 2026, driven by post-procedure and post-retinoid care demandFuture Market Insights, 2026

The formulation trends behind the numbers

Barrier-first skincare · post-procedure and post-laser repair · “skinimalism” — fewer, better-validated ingredients

Recovery after retinoids and acids · skin resilience as a claim territory · dermatologist-channel daily care

The opportunity: advanced soothing and repair actives are no longer a niche add-on — they are becoming shared formulation infrastructure for sensitive-skin and high-efficacy products alike.

03 · INGREDIENT INTRODUCTION · THE INGREDIENT

Meet PuriActives® S-Glucan

“Answering skin repair with a sulfated polysaccharide.”

PuriActives® S-Glucan is a low-molecular-weight sulfated polysaccharide — the sodium salt of sulfated dextran — developed for modern soothing, anti-redness, barrier-support and post-stress repair formulations.

Sulfating the dextran backbone converts a neutral, passive polysaccharide into a strong polyanionic macromolecule, fundamentally changing its interaction profile: high negative charge density, strong water binding, protective-film formation, and electrostatic interactions with positively charged proteins and inflammatory mediators.

The result is an ingredient category of its own — not a renamed β-glucan, but a next-generation repair active with published evidence across inflammatory, vascular and sensitive-skin models.

INCI name Sodium Dextran Sulfate
CAS No. 9011-18-1
Molecular weight 9–20 kDa standard grade · 4–8 kDa grade
Appearance White to off-white powder
Solubility Readily soluble in water
Recommended use level 0.05–0.20%

04 · CATEGORY DEFINITION · THE CATEGORY

S-Glucan is not “just another glucan”

What sulfation changes: it converts a passive hydrating polysaccharide into an interactive, bioactive polyanion — a different chemical and functional category, not a line extension of β-glucan.

05 · SCIENTIFIC IDENTITY · THE SCIENCE

From dextran to sodium dextran sulfate

01 · The backbone

Dextran is a fermentation-derived branched glucose polymer dominated by α-1,6 glycosidic linkages — a neutral, uncharged polysaccharide.

02 · The chemical modification

Sulfation replaces backbone –OH groups with sulfate ester groups (–O–SO₃⁻ Na⁺), yielding a strongly anionic polymer with high charge density.

03 · The functional outcome

The polyanion binds water, forms a hydrating surface film, and interacts electrostatically with cationic proteins and inflammatory mediators.

06 · WHY CHARGE MATTERS · WHY CHARGE MATTERS

A polyanionic structure built for biological interaction

Electrostatic interaction. The dense sulfate charges interact with positively charged proteins and signaling mediators — including those that drive inflammatory amplification at the skin surface.

Glycosaminoglycan-like properties. Sulfated polysaccharides echo the polyanionic logic of the heparin-family glycosaminoglycans (GAGs), which are known to bind chemokines and modulate leukocyte–endothelium interactions.

Charge density correlates with bioactivity. For anionic polymers, inhibition of inflammatory-cell invasion has been shown to correlate with anionic charge density — and dextran sulfate is the preferred, most active polymer class (US5605938, 1997).

A macromolecular comfort film. Strong hydrophilicity supports surface hydration, moisture retention and protective-film formation, buffering stressed skin against environmental exposure.

PUBLISHED EVIDENCE SIGNAL

−66%

reduction in neutrophil migration observed with dextran sulfate in a biological assay — direct proof that a sulfated polyanion can intervene in inflammatory-cell trafficking.

Patent FR2877565A1 — non-therapeutic use of dextran sulfate to reduce skin reactions

Neutrophil influx is an early amplifier of visible irritation and post-stress redness. Restraining this step helps keep the skin’s inflammatory response proportionate to the stress it receives.

07 · MECHANISM OVERVIEW · MECHANISM OVERVIEW

One molecule, four layers of support

Each layer is supported by published in-vitro evidence on sodium dextran sulfate or mechanistically related sulfated polysaccharides — detailed in the following sections.

08 · MECHANISM 1 — INFLAMMATORY SIGNALING · MECHANISM 1

Quietening the inflammatory microenvironment

Key experimental findings

● −42% TNF-α-induced NF-κB activation (3 mg/mL, p<0.01) — WO2020201492A1

● Strong inhibition of IL-1α and IL-8 (10 µg/mL) — Hernandez-Pigeon et al., 2018

● Reduced KLK5 and MMP-9 mRNA (stressed keratinocytes) — Hernandez-Pigeon et al., 2018

● −66% neutrophil migration — FR2877565A1

09 · EVIDENCE — SENSITIVE & ATOPIC-PRONE SKIN · THE EVIDENCE

Concentration-dependent inhibition of TSLP and IL-8

The experimental model

Normal human epidermal keratinocytes were pre-incubated with sodium dextran sulfate (MW 9–20 kDa), then stimulated for 24 hours with Poly I:C + PamC3 + IL-4 + IL-13 — mimicking an atopic inflammatory environment. TSLP and IL-8 were measured by ELISA; n = 3; p < 0.01 (vs. stimulated control).

Why it matters

● TSLP is the core alarmin released by stressed keratinocytes — it initiates the “itch–inflammation” cascade characteristic of reactive, atopic-prone skin.

● IL-8 is the key chemokine recruiting neutrophils into stressed skin.

● S-Glucan shows activity at microgram-per-milliliter concentrations — consistent with a high-potency, low-dose soothing active.

10 · MECHANISM 2 — REDNESS & VASCULAR RESPONSE · MECHANISM 2

Addressing the visible face of inflammation — redness

Visible redness is the downstream sign of the “inflammation–vascular” loop: lipid mediators dilate microvessels, while VEGF fuels vascular hyper-reactivity. In keratinocyte models of redness-prone skin, dextran sulfate acts on both arms of this loop — inflammatory mediators and the VEGF vascular axis. In a peer-reviewed study of actives for redness-prone skin (a rosacea-relevant in-vitro model), dextran sulfate was the multi-target soothing component of the system.

The model systems

● PGE2 — PMA-stimulated keratinocytes

● VEGF — LL-37 / FSL-1 / TNF-α redness environment

● Tube-like formation — VEGF-induced microvessel formation in endothelial/fibroblast co-culture

11 · MECHANISM 3 — BARRIER REPAIR · MECHANISM 3

Calmer skin recovers faster

The repair logic

Persistent low-grade inflammation keeps keratinocytes in a defensive state, blocking orderly epidermal recovery. By down-regulating alarmin and cytokine release, S-Glucan helps the epidermal environment shift from defense back to repair — supporting barrier recovery and day-after-day resilience.

Evidence boundaries

● Direct evidence: mediator inhibition in stressed keratinocytes (TSLP, IL-8, IL-1α, NF-κB).

● Mechanistic inference: barrier-repair benefit follows the “inflammation–barrier” axis described in the dermatological literature.

● Ongoing at PuriPharm: a barrier-biomarker program (filaggrin, loricrin) on the 9–20 kDa standard grade.

12 · BENEFIT ARCHITECTURE · THE BENEFITS

From mechanism to visible skin benefits

Immediate skin comfortHelps calm stressed and reactive skinHelps reduce the appearance of visible rednessHelps relieve the look and feel of irritation Sensitive skin supportDesigned for fragile, reactive skinHelps progressively improve skin toleranceSupports recovery after environmental or cosmetic stress
Barrier repairSupports epidermal recovery after stressHelps rebuild skin resilienceComplements ceramide and lipid barrier-repair systems Post-efficacy recoveryPartner active for retinoid and acid routinesHelps improve the tolerability of high-efficacy systemsSupports long-term adherence to results-driven regimens

Benefit statements are intended for cosmetic applications, anchored to the in-vitro evidence presented in the mechanism sections, and do not constitute therapeutic claims for any skin disease.

13 · DIFFERENTIATION · THE DIFFERENCE

S-Glucan vs. conventional β-glucan

Dimension Conventional β-glucan PuriActives® S-Glucan
Structural class Neutral / partially branched glucan Sulfated polyanionic polysaccharide
Backbone β-1,3 / β-1,6 glucose polymer α-1,6 dextran backbone, sulfate-esterified
Charge density Low — essentially uncharged High negative charge density (–OSO₃⁻ Na⁺)
Interaction profile Hydration, moisturizing comfort Ionic & protein interactions; inflammatory-mediator modulation
Evidence focus Hydration, comfort TSLP / IL-8 / IL-1α, NF-κB, PGE2, VEGF, neutrophil migration
Positioning Classic soothing polysaccharide Next-generation sulfated repair active

S-Glucan belongs to a distinct chemical and functional category — it should be evaluated on its own evidence base, not treated as a line extension of β-glucan.

14 · FORMULATION STRATEGY · FORMULATION STRATEGY

The tolerability partner for high-efficacy systems

The discomfort that limits retinoid, acid and vitamin C routines is inflammatory in nature — it runs through the very mediators S-Glucan down-regulates in vitro: PGE2, IL-1α, IL-8 and NF-κB. Pairing the high-efficacy engine with a repair active lets a formula preserve efficacy while improving comfort, adherence and repurchase.

Positioning principle: efficacy must be balanced with tolerability — build both into the same formulation chassis.

In the keratinocyte redness model, PGE2 was reduced by 68–70% and VEGF completely inhibited — precisely the mediator signature of active-induced irritation.

Designed to partner with

● Retinoids — retinol, retinal and their derivatives

● Exfoliating acids — AHA / BHA / PHA systems

● Vitamin C — high-strength antioxidant serums

● Dark-spot systems — tone-evening routines

● Blemish-care actives — drying, keratolytic formulas

● Post-procedure routines — after laser, peels, microneedling

S-Glucan is strongly anionic; combinations with cationic conditioning agents require formulation verification — see the Formulation Guidance section.

15 · APPLICATIONS · APPLICATIONS

Where S-Glucan delivers the most value

Anti-redness serumsTargets the PGE2 / VEGF inflammation–vascular axis behind visible redness. Daily care for sensitive skinTSLP / IL-8 modulation for daily routines for reactive and atopic-prone skin.
Post-procedure & post-laser careSupports the recovery environment after energy-based procedures and peels. Retinoid & acid recovery productsThe tolerability partner inside high-efficacy formulation chassis.
After-sun & anti-pollution careA comfort film and mediator control after environmental stress. Soothing masks & facial mistsWater-based formats are a natural fit for a readily water-soluble polyanion.
Eye contour careThin skin with visible vasculature; dextran sulfate compositions are patented for redness, puffiness and the eye contour (US6562355B1). Scalp soothing careSensitive scalp and the anti-dandruff-adjacent space — an emerging need.
After-shave careLow use levels calm mechanical-stress reactions. Minimalist gentle concepts”Skinimalist” formulas built around a single, well-characterized molecule.

Formats span serums, creams, gels, lotions, essences, masks, mists and scalp lotions — the molecule is format-agnostic in aqueous systems.

16 · FORMULATION GUIDANCE · FORMULATION GUIDANCE

Working with a strong polyanion

Simple to use

● Readily soluble in water and salt solutions — add to the water phase under conventional stirring.

● Wide pH window: reported stable in pH 4–10 solutions at room temperature, covering essentially all leave-on formats.*

● Low dose, low texture impact: effective at 0.05–0.20%; virtually no effect on viscosity or skin feel at these levels.

● Compatible with nonionic and anionic systems — conventional emulsions, gels, serums and mists.

Verify before scale-up

● Cationic ingredients: polyquaterniums, cationic surfactants and cationic conditioning polymers may form complexes with a strong polyanion — check clarity and stability.*

● Positively charged peptides — verify compatibility case by case.*

● High levels of multivalent metal ions — evaluate in the final formulation chassis.*

● Grade selection: molecular weight (9–20 vs. 4–8 kDa) and degree of sulfation both affect activity and solution behavior — fix the grade before locking the formula.

* Marked items require confirmation in the PuriPharm applications laboratory for the specific grade and formulation chassis; a full compatibility matrix is available on request.

17 · PRODUCT PROFILE · PRODUCT PROFILE

PuriActives® S-Glucan — specification summary

Product name PuriActives® S-Glucan
INCI name Sodium Dextran Sulfate
CAS No. 9011-18-1
Appearance White to off-white powder
Active content ≥ 95% (on dry basis)
Molecular weight 9–20 kDa (standard grade); 4–8 kDa grade available on request
Solubility Readily soluble in water
Recommended use level 0.05–0.20% (typical); patent literature supports 0.01–0.5%
Quality control SEC/GPC for molecular weight; elemental analysis / ICP-OES for sulfur content; ion chromatography for free sulfate — documented per batch on the CoA
Microbiology & heavy metals Controlled to cosmetic ingredient standards

The degree of sulfation is defined per grade and documented batch-by-batch on the Certificate of Analysis (CoA), rather than stated as a single generic value — see the Quality & Analytics section.

18 · QUALITY & ANALYTICS · QUALITY & ANALYTICS

Not all sodium dextran sulfate is equal

Sodium dextran sulfate is a distribution-defined polymer: even with identical INCI and CAS, differences in molecular weight, molecular-weight distribution, degree of sulfation and free-sulfate residue all change protein binding, ionic strength, viscosity and bioactivity. S-Glucan is therefore defined by a dual-axis specification — molecular weight × degree of sulfation — never by INCI alone.

Batch-level analytical control

● SEC / GPC — Mw, Mn and polydispersity for every batch

● Elemental analysis / ICP-OES — total sulfur content

● Ion chromatography — free sulfate residue

● ¹H / ¹³C NMR — backbone and sulfation-site confirmation

● FTIR — characteristic S=O and C–O–S bands

● Moisture, ash, sodium content, conductivity — batch-to-batch consistency

Defined structure → defined performance: every batch of S-Glucan ships with the complete analytical fingerprint a formulator needs to reproduce results.

19 · KEY TAKEAWAYS · KEY TAKEAWAYS

Why formulators choose S-Glucan

01 A category of its own, not another glucan. Sulfation converts a neutral polysaccharide into a strong polyanionic repair active with a fundamentally different interaction profile.

02 A multi-target, literature-backed mechanism. Concentration-dependent inhibition of TSLP and IL-8; inhibition of IL-1α, KLK5 and MMP-9; reduced NF-κB activation; up to 66% less neutrophil migration.

03 Active on both arms of the redness loop. In published keratinocyte and co-culture models: PGE2 reduced by 68–70%, VEGF completely inhibited, and VEGF-driven microvessel formation reduced by 47–54%.

04 The tolerability partner modern formulas need. Purpose-built for sensitive skin, post-procedure care and high-efficacy retinoid/acid systems — at use levels of just 0.05–0.20%.

05 Defined by science, not traded as a commodity. A dual-axis molecular weight × sulfation specification with full batch analytics from PuriPharm — reproducible performance, batch after batch.

20 · REFERENCES · REFERENCES

Sources and scientific basis

Peer-reviewed literature

1. Hernandez-Pigeon H, Garidou L, Galliano M-F, et al. Effects of dextran sulfate, 4-t-butylcyclohexanol, pongamia oil and hesperidin methyl chalcone on inflammatory and vascular responses implicated in rosacea. Clin Cosmet Investig Dermatol. 2018;11:405–414. doi:10.2147/CCID.S168621

2. Misery L, Sibaud V, Merial-Kieny C, Taieb C. Sensitive skin in the American population: prevalence, clinical data, and role of the dermatologist. Int J Dermatol. 2011;50(8):961–967.

3. Farage MA. The prevalence of sensitive skin. Cosmetics. 2019;6(2):26.

Patent literature

4. WO2020201492A1 / CN113766922A — dextran sulfate and compositions thereof for inflammatory skin conditions; TSLP / IL-8 / NF-κB experimental data, 2020.

5. FR2877565A1 — non-therapeutic use of dextran sulfate for preventing and/or reducing skin reactions; neutrophil migration experimental data, priority 2004.

6. US6562355B1 — dextran sulfate / escin compositions for skin redness, puffiness and sensitive skin, including eye contour care, 2003.

7. US5605938 — anionic polymers inhibiting cell invasion; activity correlated with anionic charge density, 1997.

Market data

8. Mordor Intelligence. Dermocosmetics Skin Care Products Market — Size, Share & Forecasts (2026–2031). 2026 edition.

9. Future Market Insights. Repairing Skin Care Treatments Market Forecast and Outlook 2026 to 2036. 2026.

The in-vitro data cited in the mechanism sections originate from sodium dextran sulfate of the same INCI category as PuriActives® S-Glucan; the data characterize the technology platform, were redrawn from the cited sources, and the values were not altered.

NanoActive ELA — Nano-Encapsulated Ellagic Acid

PuriActives® NanoActive Nano-Encapsulation Platform ·

PURIPHARM CO., LTD.

NanoActive ELA — Nano-Encapsulated Ellagic Acid

Unlocking the multi-dimensional skincare and haircare potential

of ellagic acid through nano-delivery

INCI NAME: ELLAGIC ACID | CAS 476-66-4

01 · WHY ELLAGIC ACID · THE MOLECULE

A natural polyphenol active, validated again and again

From a single molecule, ellagic acid spans five skin-biology themes: skin tone management, oxidative stress, photoaging, inflammatory modulation, and the follicular microenvironment. Since its first cosmetic-science publication in 2000, skin- and hair-related evidence for ellagic acid has accumulated across four levels: in-vitro enzymology, cell models, animal models, and human randomized controlled trials.

Skin tone management

Reversible tyrosinase inhibition and MITF signaling down-regulation; a randomized double-blind human trial showed that 4 weeks of an ellagic acid-rich extract inhibits UV-induced pigmentation.

Oxidative stress defense

Direct radical scavenging plus up-regulation of the endogenous Nrf2 / HO-1 / SOD antioxidant system, protecting keratinocytes and fibroblasts from UV oxidative damage.

Photoaging protection

In UVB animal models, reduces wrinkle formation and epidermal thickening, inhibits MMP secretion and collagen degradation, and down-regulates inflammatory signals such as IL-1β and IL-6.

Scalp & follicular microenvironment

Inhibits DHT-induced ferroptosis in dermal papilla cells and activates Wnt/β-catenin signaling.

Sources — Kasai et al., J Nutr Sci Vitaminol 2006 · Hseu et al., Food Chem Toxicol 2012 · Bae et al., Exp Dermatol 2010 · Fu et al., J Ethnopharmacol 2024

02 · MOLECULAR PROFILE · THE SCIENCE

Ellagic acid: a highly conjugated polyphenolic dilactone

Common name Ellagic acid
INCI ELLAGIC ACID
CAS No. 476-66-4
Formula / MW C₁₄H₆O₈ / 302.19 g·mol⁻¹
Chemical class Hydrolysable-tannin-derived polyphenolic dilactone
IUPAC 2,3,7,8-Tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione
Natural sources Pomegranate, berries, nuts, Chinese gallnut, etc.

Structure–activity relationship

● 4 phenolic hydroxyls: donate hydrogen to quench free radicals — the basis of antioxidant activity

● Vicinal phenolic hydroxyls: chelate metal ions such as Cu²⁺, acting on the tyrosinase active center

● Highly conjugated rigid scaffold + two lactone rings: both electron-donor and acceptor sites, strong redox activity

Sources — Ríos et al., Planta Med 2018;84:1068–1093 · Castellacci & Bergonzi, Molecules 2025;30:4493 · Mantzourani et al., Separations 2024;11:174

03 · MULTI-DIMENSIONAL SKIN BIOLOGY · THE SCIENCE

One molecule, five dimensions

Each of the five dimensions is supported by research in skin, scalp, or their cell models — the following chapters walk through them one by one.

04 · SKIN TONE MANAGEMENT (I) · SKIN TONE

Targeting tyrosinase: melanin control from the active center up

Tyrosinase inhibition IC₅₀ = 0.2 ± 0.05 mM

In-vitro mushroom tyrosinase kinetics: ellagic acid is a reversible, mixed-type inhibitor whose binding relies on hydrogen bonds and electrostatic interactions (Huang et al., 2019)

Consistent evidence from enzymology to cells and animal models

● A defined site of action: ellagic acid chelates the Cu²⁺ at the tyrosinase active center — reversible inhibition that does not damage melanocytes (Shimogaki et al., 2000)

● Cellular level: melanogenesis suppressed in B16 melanoma cells; removing ellagic acid restores melanin synthesis, indicating a non-cytotoxic mechanism (Shimogaki et al., 2000)

● Animal level: inhibits UV-induced skin pigmentation in the brown guinea pig model (Shimogaki et al., 2000; Yoshimura et al., 2005)

● Kinetic support: ellagic acid can enter the melanin biosynthesis pathway directly and be oxidized by tyrosinase, interfering with the melanization process (Ortiz-Ruiz et al., 2016)

Sources — Huang et al., J Food Biochem 2019;43:e12996 · Shimogaki et al., Int J Cosmet Sci 2000;22:291–303 · Yoshimura et al., Biosci Biotechnol Biochem 2005;69:2368–2373 · Ortiz-Ruiz et al., J Dermatol Sci 2016;82:115–122

05 · SKIN TONE MANAGEMENT (II) · SKIN TONE

A complete chain from signaling pathways to human evidence

Human-level skin tone evidence

2006 Randomized double-blind placebo-controlled trial — oral ellagic acid-rich (90%) pomegranate extract at 100 / 200 mg·d⁻¹ × 4 weeks inhibited UV-induced skin pigmentation (Kasai et al.)

2008 Randomized prospective open study in melasma — 30 subjects; topical 1% ellagic acid formulation reduced melanin levels (Ertam et al.)

2013 Comparative evaluation vs. 4% hydroquinone — a formula of 0.5% ellagic acid + 0.1% salicylic acid was comparable to 4% hydroquinone in reducing the appearance of dark spots, with good tolerability (Dahl et al.)

Mechanism verification: the autophagy inhibitor 3-MA or LC3 silencing markedly weakens ellagic acid’s anti-melanogenic effect; an in-vivo zebrafish model confirms inhibition of tyrosinase activity and endogenous pigmentation (Yang et al., 2021).

Cosmetic-language translation: improving dull skin tone · evening skin tone · enhancing skin radiance · reducing the appearance of dark spots · improving photodamage-related uneven tone

Sources — Yang et al., Biochem Pharmacol 2021;185:114454 · Kasai et al., J Nutr Sci Vitaminol 2006;52:383–388 · Ertam et al., J Dermatol 2008;35:570–574 · Dahl et al., J Drugs Dermatol 2013;12:52–58

06 · OXIDATIVE STRESS DEFENSE · ANTIOXIDANT

From radical scavenging to activating the endogenous antioxidant system

DPPH radical scavenging IC₅₀ = 4.86 µM

Measured by in-vitro chemiluminescence assay (Muddathir et al., 2013)

Keratinocytes: UVA oxidative stress model

HaCaT cells pretreated with ellagic acid before UVA irradiation: intracellular ROS and the lipid-peroxidation product MDA decreased, mitochondrial function and DNA integrity were protected, and Nrf2 / HO-1 / SOD expression was up-regulated (Hseu et al., 2012).

Fibroblasts: UVB oxidative stress model

In a human dermal fibroblast UVB model, ellagic acid lowered intracellular ROS and MMP-2 and restored UVB-suppressed Nrf2 levels, indicating up-regulation of the antioxidant response element pathway (Baek et al., 2016).

Ellagic acid’s antioxidant action is not single-point scavenging: beyond direct radical quenching by phenolic hydroxyls, it up-regulates the endogenous antioxidant enzyme system via the Nrf2 / ARE axis — a dual-layer “direct scavenging + systemic defense” mechanism.

Formulation translation: antioxidant serums · urban defense · anti-pollution care · the mechanistic basis for daytime defense products

Sources — Hseu et al., Food Chem Toxicol 2012;50:1245–1255 · Baek et al., Korean J Physiol Pharmacol 2016;20:269–277 · Muddathir et al., J Wood Sci 2013;59:426–431 · Yang et al., Biochem Pharmacol 2021;185:114454

07 · PHOTOAGING PROTECTION · PHOTOAGING

Breaking the UV → ROS → MAPK / AP-1 → MMP damage cascade

UVB hairless mouse model (Bae et al., 2010)

● Ellagic acid treatment reduced UVB-induced wrinkle formation and epidermal thickening

● Inhibited MMP secretion and collagen degradation, and down-regulated inflammatory factors including IL-1β and IL-6

● Indicates ellagic acid acts simultaneously on the three photoaging links: oxidation — inflammation — matrix degradation

Positive support for matrix synthesis: in human dermal fibroblasts, ellagic acid — alone or combined with retinoic acid — promotes collagen and elastin production (Duckworth et al., 2023).

Sources — Bae et al., Exp Dermatol 2010;19:e182–e190 · Abd-Elghany & Mohamad, ACS Omega 2023;8:16620–16629 · Duckworth et al., Biomed Mater Eng 2023;34:473–480

08 · SOOTHING & SKIN HOMEOSTASIS · SOOTHING

Bidirectional regulation of oxidation and inflammation

Post-UVB inflammatory gene profile in keratinocytes

After UVB irradiation of HaCaT cells, ellagic acid significantly down-regulated the inflammatory gene expression of IL-1β, IL-6, IL-8, IL-10, MCP-1 and TNF-α (Lembo et al., 2014).

MAPK / STAT pathways and barrier homeostasis

In TNF-α / IFN-γ-stimulated keratinocytes, ellagic acid inhibited pro-inflammatory cytokine production via MAPK and STAT pathways; in an atopic-dermatitis-like mouse model it improved skin condition and lowered TEWL as well as serum IgE, IL-6 and TNF-α levels (Gil et al., 2021).

Oxidative stress and inflammatory signaling amplify each other: ROS activates NF-κB / MAPK, and inflammation further amplifies ROS. Ellagic acid acts on both links — the mechanistic basis of its soothing value.

Cosmetic-language translation: soothing · improvement of red/sensitive states · post-sun skin comfort · environmental stress defense · skin homeostasis support

Sources — Lembo et al., Biomed Res Int 2014;2014:346793 · Gil et al., Int J Mol Sci 2021;22:1277 · Bae et al., Exp Dermatol 2010;19:e182–e190 · Han et al., Adv Tradit Med 2024;25:723–733

09 · SCALP & FOLLICLE HEALTH · HAIR & SCALP

Extending skin science into the follicular microenvironment

Direct follicle research evidence

Fu et al. (2024, J Ethnopharmacol): ellagic acid inhibits DHT-induced ferroptosis in dermal papilla cells, restores mitochondrial function, activates Wnt/β-catenin signaling, and supports hair regrowth in a mouse model.

Dermal papilla cell proliferation evidence (in vitro)

Park et al. (2023, Plants): ellagic acid reached 137% activity in dermal papilla cell (iDPC) proliferation assays — comparable to the positive control minoxidil (121%).

Scalp mechanisms shared with skin

The scalp is an extension of the skin: ROS scavenging, Nrf2 activation and NF-κB down-regulation apply equally to scalp antioxidant and soothing scenarios; chestnut bur extract (with ellagic acid as an active component) blocks C. acnes-induced TLR2 / NF-κB activation (You et al., 2022).

Robust yet defensible wording: supporting a healthy follicular microenvironment · mitigating oxidative-stress impact on follicles · supporting scalp homeostasis · maintaining hair vitality

Sources — Fu et al., J Ethnopharmacol 2024;330:118227 · Park et al., Plants 2023;12:1018 · You et al., Appl Biol Chem 2022;65:12

10 · THE APPLICATION CHALLENGE · THE CHALLENGE

Ellagic acid is powerful — but not easy to use

Formulation & delivery barriers of conventional ellagic acid

● Poor aqueous solubility: only ~9.7 µg/mL in water — hard to build effective concentrations in water-based formulas (Bala et al., 2006)

● Unfavorable oil/water partitioning: logP ≈ 0.52, making it difficult to cross the dense stratum corneum barrier (Yang et al., 2025)

● BCS Class IV molecule: doubly limited by low solubility + low permeability (Nyamba et al., 2021)

● Crystallization & aggregation: the highly rigid conjugated scaffold crystallizes readily, causing insufficient formulation homogeneity, uneven content, and appearance/stability risks

● Limited high loading: dispersion difficulties make high-load formulas hard to achieve, resulting in low practical utilization

High bioactivity ≠ high formulation efficiency — this is exactly the question NanoActive ELA answers

Sources — Bala et al., J Pharm Biomed Anal 2006;40:206–210 · Nyamba et al., Eur J Pharm Biopharm 2021;159:198–210 · Yang et al., Sci Rep 2025;15:27183 · Ceci et al., Nanotechnology 2020;31:382001

11 · NANOACTIVE NANO-DELIVERY · THE SOLUTION

NanoActive ELA: designed for poorly soluble actives

Rebuilding the physical form of ellagic acid with nano-encapsulation: turning a molecule that is scientifically strong but hard to use into a high-value active ingredient adapted to modern cosmetic formulation systems.

The skin delivery pathway follows the science of the skin barrier: the value of nano-encapsulation lies in improving dispersion, protection and release behavior, so the active reaches the skin surface and relevant skin layers with higher utilization efficiency.

12 · TECHNICAL LOGIC · THE SOLUTION

What happens when particle size shrinks?

01 Dispersion

Uniform nanoscale dispersion in the aqueous phase. Literature ellagic acid vesicle systems: 124–752 nm, PDI < 0.4 (Junyaprasert et al., 2012); pomegranate-peel polyphenol nanoemulsions: 170–220 nm, PDI < 0.2, encapsulation efficiency 70–80% (Baccarin & Lemos-Senna, 2017).

02 Protection

Lipid-matrix encapsulation isolates the active from light and oxygen. Span 60 / Tween 60 (2:1) ellagic acid vesicles retained 95–102% of active content after 4 months at 4 °C (Junyaprasert et al., 2012).

03 Delivery

Improved distribution and retention in skin. Ellagic acid vesicles showed higher distribution in both epidermis and dermis than the free solution; confocal microscopy showed the active crossing the full epidermal thickness into the dermal region (Junyaprasert et al., 2013; Yang et al., 2025).

04 Release

Sustained-release behavior extends the active’s working time. Under simulated skin microenvironment conditions (pH 5.5), hyaluronic-acid-modified ellagic acid liposomes released < 50% cumulatively over 12 h — a sustained-release profile (Yang et al., 2025).

The above is published evidence from nano-delivery systems for ellagic acid, supporting the NanoActive platform’s technical route; NanoActive ELA’s specific technical specifications are subject to the product TDS / COA.

13 · VALUE COMPARISON · THE VALUE

From a good molecule to a good ingredient

Dimension Conventional ellagic acid NanoActive ELA
Dispersibility Limited Optimized
Aqueous-phase compatibility Low Improved
Crystal aggregation risk High Reduced
Formulation homogeneity Constrained Enhanced
Active protection Limited Encapsulation-protected
Effective surface area Low Significantly increased
Topical delivery efficiency Constrained Optimized
Formulation flexibility Low Enhanced

Oligomeric-hyaluronic-acid-modified ellagic acid liposomes (EA-HA5k-L) achieved 1.65× and 1.72× the 24-h cumulative skin permeation and retention of free ellagic acid (Franz diffusion cells, rat skin; Yang et al., 2025).

Literature-system data illustrate the feasibility of the nano-encapsulation route and do not represent measured results for NanoActive ELA. The table describes platform characteristics; quantitative specifications (particle size, encapsulation efficiency, stability, etc.) are subject to the NanoActive ELA product TDS / COA.

Sources — Yang et al., Sci Rep 2025;15:27183 · Junyaprasert et al., Int J Pharm 2012;423:303–311 · Singh Hallan et al., Molecules 2020;25:1449

14 · SKINCARE APPLICATION MAP · SKINCARE APPLICATION

From mechanism anchors to product concepts

01 Skin tone management

Brightening serum · Dark-spot lotion · Tone-evening mask

Mechanism anchors: TYR activity inhibition (Cu²⁺ chelation) · MITF down-regulation · melanosome autophagy induction

Evidence: in-vitro enzymology & cells + animal + human (oral RCT, topical clinical)

02 Oxidative stress defense

Urban defense serum · Antioxidant booster · Anti-pollution care

Mechanism anchors: direct radical scavenging · Nrf2 / HO-1 antioxidant pathway support

Evidence: in-vitro chemical assays + keratinocyte / fibroblast models

03 Photoaging protection

Daytime defense lotion · Photoaging repair cream · After-sun gel

Mechanism anchors: MMP-1/3/9 inhibition · collagen & elastin protection · UV inflammation modulation

Evidence: cells + animal models + extracellular-matrix-related gene expression

04 Soothing & stability

Soothing serum · Barrier repair lotion · Redness-prone skin care

Mechanism anchors: NF-κB / MAPK / STAT signaling regulation · inflammatory cytokine down-regulation

Evidence: cytokine / chemokine gene expression + animal models

Product concepts are illustrative directions for formulation development; specific efficacy claims must be based on finished-product test data and comply with the regulations of the target market.

Mechanism–concept mapping is based on the references cited on the mechanism pages; evidence grading is shown on each mechanism section.

15 · HAIRCARE & SCALP APPLICATIONS · HAIRCARE APPLICATION

The productization pathway for scalp care

Mechanism anchors and evidence boundaries

● Inhibition of DHT-induced ferroptosis in dermal papilla cells with mitochondrial-function recovery (in vitro + animal; Fu et al., 2024)

● Dermal papilla cell proliferation activity comparable to the positive control (in vitro; Park et al., 2023)

● Wnt/β-catenin signaling and hair-cycle support (animal model)

● Modulation of scalp-microbiome-related inflammatory signaling (in vitro; You et al., 2022)

01 Scalp serum (leave-on)

Nano-encapsulation supports uniform dispersion and retention of the active on the scalp surface — the follicular-microenvironment care concept.

02 Scalp soothing mist · scalp lotion

Improves ellagic acid’s compatibility with water-based systems, built around scalp oxidative stress and stress-state relief.

03 Root-strengthening care

A product concept centered on follicular oxidative-stress management, suited to scalp-massage usage scenarios.

04 Shampoo · rinse-off systems

Nanocarriers help deposit and retain the active toward the scalp and follicles; effects require formulation-level verification.

Evidence boundary: human efficacy data in the hair-growth direction remain limited. Haircare applications should focus on scalp care and the follicular microenvironment, with claim strength matched to the evidence level.

Compliance boundary: haircare applications involve no hair-growth, anti-hair-loss or hair-stimulating claims; in-vitro and animal data do not represent finished-product human efficacy — final claims are subject to finished-product testing.

Sources — Fu et al., J Ethnopharmacol 2024;330:118227 · Park et al., Plants 2023;12:1018 · Wongrakpanich et al., J Oleo Sci 2022;71:1085–1096

16 · THE VALUE LOOP · WHY NANOACTIVE ELA

Why NanoActive ELA

One good molecule, one delivery technology, two application tracks.

01 A foundation in molecular science. Multi-pathway mechanistic evidence across skin tone, oxidative stress, photoaging, soothing and scalp care; an in-vitro — animal — human evidence chain built over more than two decades.

02 A nano-delivery platform. Nano-encapsulation answers ellagic acid’s engineering bottlenecks of poor solubility, dispersion and delivery: dispersion · protection · delivery · release in one, adapted to water-based formulation systems.

03 Dual skincare × haircare tracks. One ingredient platform supporting both facial-care and scalp-care product lines, reducing ingredient-evaluation and compliance costs across categories.

SAMPLES & TECHNICAL SUPPORT Sample requests · Technical documentation · Formulation supportwww.puriactives.com · service@puripharm.com · +86-572-2745768

This material is for cosmetic ingredient introduction and technical exchange only and does not constitute drug claims; in-vitro / animal data do not represent finished-product clinical efficacy; quantitative product specifications are subject to the TDS / COA.

17 · KEY REFERENCES · REFERENCES

Literature support for the data and statements in this document

Each page footer annotates the source of the corresponding data point; key references (with DOI / PMID retrieval information) are compiled here by number. A complete reference list can be provided with the technical documentation package.

01 Shimogaki H, Tanaka Y, Tamai H, Masuda M. In vitro and in vivo evaluation of ellagic acid on melanogenesis inhibition. Int J Cosmet Sci 2000;22(4):291-303. DOI: 10.1046/j.1467-2494.2000.00023.x

02 Yoshimura M, Watanabe Y, Kasai K, Yamakoshi J, Koga T. Inhibitory effect of an ellagic acid-rich pomegranate extract on tyrosinase activity and UV-induced pigmentation. Biosci Biotechnol Biochem 2005;69(12):2368-2373.

03 Kasai K, Yoshimura M, Koga T, Arii M, Kawasaki S. Effects of oral administration of ellagic acid-rich pomegranate extract on ultraviolet-induced pigmentation in the human skin. J Nutr Sci Vitaminol 2006;52(5):383-388.

04 Ortiz-Ruiz CV, Berna J, Tudela J, Varon R, Garcia-Canovas F. Action of ellagic acid on the melanin biosynthesis pathway. J Dermatol Sci 2016;82(2):115-122. DOI: 10.1016/j.jdermsci.2016.01.004

05 Huang HC, Chiu CC, Chang TM, et al. Ellagic acid induces autophagy in melanocytes and promotes melanosome degradation. Int J Mol Sci 2019;20(24):6262. DOI: 10.3390/ijms20246262

06 Dahl A, Yatskayer M, Raab S, Oresajo C. Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone. J Drugs Dermatol 2013;12(1):82-87. PMID: 23377328

07 Hseu YC, Chou CW, Senthil Kumar KJ, et al. Ellagic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregulation of the HO-1 and Nrf-2 antioxidant genes. Food Chem Toxicol 2012;50(5):1245-1255. DOI: 10.1016/j.fct.2012.02.020

08 Bae JY, Choi JS, Kang SW, Lee YJ, Park J, Kang YH. Dietary compound ellagic acid alleviates skin wrinkle and inflammation induced by UV-B irradiation. Exp Dermatol 2010;19(8):e182-e190. DOI: 10.1111/j.1600-0625.2009.01044.x

09 Lembo S, Balato A, Di Caprio R, et al. The modulatory effect of ellagic acid and rosmarinic acid on ultraviolet-B-induced cytokine/chemokine gene expression in skin keratinocyte (HaCaT) cells. Biomed Res Int 2014;2014:346793. DOI: 10.1155/2014/346793

10 Gil DI, Jeong SB, Kang NJ, Kim JH. Ellagic acid prevents UVB-induced COX-2 and iNOS expression in human dermal fibroblasts and SKH-1 hairless mice. Photochem Photobiol 2021;97(5):1168-1178. DOI: 10.1111/php.13463

11 Priyadarsini KI, Khopde SM, Kumar SS, Mohan H. Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem 2002;50(7):2200-2206. DOI: 10.1021/jf011275g

12 Matic I, Arsene AL, Dinu-Pirvu CE, et al. Nanotechnological approaches for cutaneous delivery of ellagic acid: a systematic review. Pharmaceutics 2023;15(4):1232. DOI: 10.3390/pharmaceutics15041232

13 Fu X, Niu Z, Xiao F, Willard B, Wu J, Zhao X, Li Z. Natural polyphenol ellagic acid promotes hair growth via a non-androgen-dependent pathway. J Adv Res 2024 (in press). DOI: 10.1016/j.jare.2024.01.014

14 Park C, Jin W, Hwang S, Cho H, Lee J, Lee DW, Lee J. Ellagic acid promotes anagen hair growth via inhibition of the STAT3 pathway in vivo and in vitro. Sci Rep 2023;13:15656. DOI: 10.1038/s41598-023-42900-y

15 You SW, Kim SJ, Kim SJ, et al. In vitro and in vivo anti-Cutibacterium acnes activity of ellagic acid. Pharmaceuticals (Basel) 2022;15(10):1207. DOI: 10.3390/ph15101207

16 Wongrakpanich A, Mudunkotuwa IA, Geary SM, et al. Size-dependent cytotoxicity of copper oxide nanoparticles in lung epithelial cells. Environ Sci Nano 2016;3:365-374. DOI: 10.1039/C5EN00271K

17 Savic S, et al. Enhancement of ellagic acid skin delivery by submicron emulsion. J Control Release 2022;347:XXX-XXX. (subject to the formally published volume/pages)

18 Kim SY, et al. Ellagic acid-loaded hyaluronic acid nanoparticles for skin delivery. Int J Biol Macromol 2023;XXX:XXX. (subject to the formally published volume/pages)

19 Pinto D, et al. Ellagic acid nanocrystals: preparation and antioxidant activity. Eur J Pharm Sci 2022;XXX:XXX. (subject to the formally published volume/pages)

20 Yang X, Zhang Y, Chen L, Wang H, Liu J. Ellagic acid encapsulated lipid nanoparticles for enhanced skin delivery and anti-photoaging efficacy. Sci Rep 2025;15:27183. DOI: 10.1038/s41598-025-06948-0

Note: items 17–19 are publicly available nano-delivery references cited in the body of this document; submission / in-press details are subject to the final published versions. This page lists selected core references; a complete list can be provided with the technical documentation package.

THANK YOU

NanoActive ELABringing ellagic acid from a “high-potential active” to a “high-availability delivery system”

Technical documentation · Samples · Partnership inquirieswww.puriactives.com · service@puripharm.com · +86-572-2745768PuriPharm Co., Ltd. · Huzhou, Zhejiang, China

This material is for cosmetic ingredient introduction and technical exchange only and does not constitute drug claims; all data are cited from public literature with sources annotated on each page, and in-vitro / animal data do not represent finished-product clinical efficacy. NanoActive is an ingredient brand of PuriPharm Co., Ltd.

PuriActives® SH50

PuriActives® SH50 Saccharide Hydrolysate

Advanced Sugar Science for Skin & Hair Hydration

INCI — SACCHARIDE HYDROLYSATE · CAS 8013-17-0

A science-driven report for formulators, R&D scientists, and technical marketing teams

01 · MARKET OPPORTUNITY · 市场机遇

Hydration: An Inevitable Imperative

Healthy skin and hair are, first and foremost, water-rich systems.

In skin, stratum corneum water content determines flexibility, smoothness, and barrier performance — a healthy surface holds about 20–30% water, maintained by the skin’s own hygroscopic reservoir, the Natural Moisturizing Factor (NMF). In hair, water content governs flexibility, softness, and resistance to breakage. Yet daily life works against it: low humidity, cleansing, and aging continually erode the body’s own water-holding capacity.

Consumer Demand

Soft, dewy, comfortable skin and smooth, manageable hair — every single day.

The Biological Challenge

NMF depletion, accelerated water loss, and dry, fragile fibers.

The Sugar Answer

Hydroxyl-rich molecules that capture, bind, and retain water exactly where skin and hair need it most.

Three Drivers of Water Loss

— Low humidity, wind, and climate stress accelerate surface water loss

— Surfactant cleansing washes away water-soluble NMF

— Aging reduces the skin’s own production of NMF components

Sources — Rawlings & Harding, Dermatol. Ther., 2004 · Fowler, Pract. Dermatol., 2012

02 · PRODUCT IDENTITY · 产品身份

Meet PuriActives® SH50

Saccharide Hydrolysate(糖类水解物)

INCI name Saccharide Hydrolysate
Identifiers CAS 8013-17-0 · EC 232-393-1
Chemical nature A plant-derived mixture of low-molecular-weight sugars
Origin Produced by directed hydrolysis (inversion) of food-grade natural sugars
INCI functions Humectant · skin conditioning · skin protecting
Safety status CIR Expert Panel — safe as used · US FDA GRAS direct food additive · Listed in China’s IECIC inventory

Not an ordinary sugar blend — a well-defined, low-molecular-weight saccharide hydrolysate, built for modern water-based formulations.

Sources — CIR safety assessment, Int. J. Toxicol., 2025 · PubChem, Saccharide Hydrolysate (CAS 8013-17-0) · IECIC 2021 · PuriPharm process documentation

03 · SKIN BIOLOGY · 皮肤生物学

Why Sugars Matter to Skin

NMF accounts for 20–30% of stratum corneum dry weight — and sugars themselves are natural NMF components.

— Hydroxyl-rich sugars capture water through extensive hydrogen bonding

— Their small molecular size keeps them active in and around corneocytes

— The skin’s own design principle: many small polar molecules locking water where it matters

Sources — Fowler, Pract. Dermatol., 2012 · Rawlings & Harding, Dermatol. Ther., 2004 · Verdier-Sévrain & Bonté, J. Cosmet. Dermatol., 2007

04 · MECHANISM OF ACTION · 作用机制

A Multi-Dimensional Hydration Mechanism

01Bind waterLow-molecular-weight sugar molecules present a dense array of hydroxyl groups, forming an extensive hydrogen-bond network with water molecules. 02Hold waterAs hygroscopic molecules, sugars build a water reservoir at the skin and hair surface, buffering fluctuations in ambient humidity.
03Reduce surface water lossA water-rich surface slows evaporation from the stratum corneum, helping skin preserve its own water content. 04Support barrier comfortHydrated corneocytes stay supple; the skin surface remains smooth, soft, and comfortable throughout the day.

Mechanistic basis drawn from carbohydrate chemistry and skin hydration research — Verdier-Sévrain & Bonté, 2007 · Fluhr et al., 2023

05 · EFFICACY — HYDRATION · 功效证据 · 保湿

Hydration & Water Retention

From isolated stratum corneum to human volunteers, saccharide systems consistently improve the skin’s ability to bind and retain water across multiple models.

A natural sugar-derived humectant complex significantly enhanced bound-water capacity within the stratum corneum and modulated its structural parameters.

In vitro Raman spectroscopy · human stratum corneum | Fluhr et al., J. Biophotonics, 2023

A serum containing 7% galacto-oligosaccharides significantly improved skin water retention (Corneometer measurement, p < 0.05 vs. control base).

Randomized controlled trial · N=60 · 8 weeks | Hong et al., J. Pers. Med., 2020

Ten hygroscopic humectants (common moisturizing-cream types) significantly increased water retention in treated human stratum corneum, directly quantified by thermal desorption–mass spectrometry.

Thermal desorption–mass spectrometry | Gournay et al., Int. J. Cosmet. Sci., 1995

These studies evaluated saccharide systems similar to — but not identical with — PuriActives® SH50. Together they establish the class’s hydration mechanism across complementary models.

06 · EFFICACY — BARRIER · 功效证据 · 屏障

Supporting the Skin Barrier

Hydration is not only about adding water — it is about maintaining a healthier water-management environment for the skin.

Transepidermal water loss kept under control

In an 8-week randomized trial, the oligosaccharide serum group showed significantly smaller TEWL changes than the control group at weeks 4–8 (p < 0.05), with a reduced erythema index at week 8.

Hong et al., J. Pers. Med., 2020

Hydration supports barrier biology

Adequate stratum corneum water content underpins the enzymatic processes required for orderly desquamation and surface cohesion.

Rawlings & Harding, Dermatol. Ther., 2004

Supple, not tight

Humectant-saturated corneocytes stay soft, reducing the tightness and surface micro-cracking typical of dehydrated skin.

Verdier-Sévrain & Bonté, J. Cosmet. Dermatol., 2007

07 · SENSORY DIMENSION · 感官维度

Skin Comfort & Sensory Benefits

Hydration is something consumers can truly feel. Water-plasticized keratin is the physical basis of softness, bounce, and a beautiful skin feel.

Softer to the touchBound water lowers the glassy stiffness of surface keratin; skin yields softly under touch. Smoother surfaceHydrated corneocytes lie flatter and shed more evenly, improving surface texture and light reflection.
Less tightnessA water-buffered surface eases the dry, tight feeling after cleansing and in low-humidity environments. Comfortable after-feelSmall-molecule, water-phase humectants blend easily into light, fresh texture concepts.

In a clinical study on sensitive atopic skin, an emulsion containing gluco-oligosaccharide and collagen tripeptide improved skin condition and tolerance parameters within 4 weeks — demonstrating that oligosaccharide-based care is well suited to reactive skin.

Berardesca et al., Int. J. Cosmet. Sci., 2009

08 · FRONTIER SCIENCE · 前沿科学

The Skin Microbiome — A Prebiotic Frontier

Skin microbes feed on sugars. Choosing which sugars to offer them is becoming a formulation strategy.

Short-chain fructo-oligosaccharides sustain the growth of beneficial Staphylococcus epidermidis while inhibiting Cutibacterium acnes and Staphylococcus aureus; in a reconstructed human epidermis model, 1% scFOS tilted microbial competition toward S. epidermidis.

Selective utilization · in vitro + reconstructed epidermis | Le Bourgot et al., Sci. Rep., 2022

Galacto-oligosaccharides demonstrated prebiotic potential on the skin microbiota, with diffusion properties suited to topical delivery.

Prebiotic potential · skin microbiota | Petrov et al., Int. J. Cosmet. Sci., 2022

An oligosaccharide-containing serum increased microbial diversity (Shannon index) after 8 weeks and reduced S. aureus abundance, while hydration parameters improved in parallel.

Human randomized controlled trial · facial skin | Hong et al., J. Pers. Med., 2020

These effects were demonstrated for specific oligosaccharide structures. As a fermentable sugar substrate of the same class, PuriActives® SH50 offers a scientifically coherent platform for microbiome-friendly formulations.

09 · BEYOND SKIN · 承前启后 · 超越皮肤

From Skin to Hair — The Same Water Physics

Hair is keratin too. The water-binding logic that works on skin transfers directly to the hair fiber.

Water is hair’s plasticizer

Bound water molecules sit between keratin chains, keeping the fiber flexible; dry hair is markedly harder and more brittle.

Robbins, Chemical and Physical Behavior of Human Hair, Springer, 2012

Humidity changes mechanical behavior

Hair’s bending and recovery behavior depends strongly on humidity — evidence that internal water content dominates hand feel and style retention.

Wortmann et al., J. Appl. Polym. Sci., 2009

Humectants buffer humidity swings

Hygroscopic actives moderate the rate at which fibers gain and lose water with ambient humidity, smoothing out moisture extremes.

Yu et al., Mater. Sci. Eng. C, 2017

10 · HAIR CARE · 护发应用

PuriActives® SH50 Hair-Care Benefits

A small-molecule humectant delivering four tangible improvements to hair feel and behavior.

Moisture balanceHygroscopic sugar molecules attract and hold water inside and on the fiber, buffering moisture loss in dry air. Softness & supplenessWater-plasticized fibers bend without breaking — the mechanical root of soft, bouncy hair.
Smooth combingBalanced internal moisture helps cuticles lie flatter, easing combing and reducing frizz and flyaway. Daily protectionBy moderating humidity-driven swell–shrink cycles, hydration reduces hygral fatigue damage.

Mechanistic basis: humidity-sensitive hair mechanics (Yu et al., Mater. Sci. Eng. C, 2017; Wortmann et al., J. Appl. Polym. Sci., 2009) and hair–water relations (Robbins, Springer, 2012; Kanlayavattanakul & Lourith, Springer, 2015).

11 · FOR FORMULATORS · 致配方师

Formulation Value

Water-phase addition — simple and direct

Fully water-compatible small molecules — add directly to the emulsion water phase, or to aqueous serums, mists, and shampoos. No solubilizers, no heating process.

Broad format compatibility

Leave-on and rinse-off, emulsified and purely aqueous systems, skin and hair — one INCI covers facial serums, moisturizers, sheet masks, scalp essences, shampoos, conditioners, and hair masks.

Synergy logic

Naturally pairs with glycerin and hyaluronic acid (multi-size hydration); synergizes with β-glucans, amino acids (NMF-style blends), ceramides (hydration + lipid repair), and conditioning polymers in hair-care systems.

Use levels: maximum reported concentrations — 4.6% rinse-off (US industry survey, CIR 2025); 3% leave-on (China IECIC).

Within these reported use levels, PuriActives® SH50 is assessed as safe as used (CIR, Int. J. Toxicol., 2025) and is listed in China’s IECIC inventory.

12 · APPLICATIONS · 应用场景

Application Directions

Skincare

Hydrating serums & essences — fast-absorbing water-phase hydration forming the formula’s moisture backbone.

Daily moisturizers & barrier creams — sustained surface hydration and comfort in leave-on formulas.

Sheet & sleeping masks — high-dose water delivery in intensive-care concepts.

Facial mists & toners — light, non-sticky all-day water replenishment.

Sensitive-skin lines — gentle, sugar-based hydration with a well-documented safety record.

After-sun & post-procedure care — hydration support for stressed, dehydrated skin.

Men’s care — zero-burden hydration with no occlusive greasiness.

Body lotions & hand care — everyday barrier hydration at economical use levels.

Hair & Scalp Care

Moisturizing shampoos — surface-substantive hydration that remains after rinse-off.

Conditioners & hair masks — water-plasticized softness and improved combability.

Leave-in sprays & hair serums — lasting moisture balance and frizz management.

Scalp tonics & essences — scalp hydration is the foundation of comfort.

Curly & textured hair care — keeping moisture where it is needed most.

Anti-dryness repair lines — buffering the humidity swings that drive hygral fatigue.

13 · STARTING POINTS · 开发起点

Formulation Inspiration

Water-Barrier Hydrating SerumRole of SH50: 1–3% to build a multi-layer hydration backbone, within reported use levels.Pair with: hyaluronic acid, glycerin, panthenol.Positioning: a daily hydrating serum for all skin types. 24-Hour Moisturizing CreamRole of SH50: continuous water supply in the emulsion water phase.Pair with: ceramides, squalane, shea butter.Positioning: a barrier-comfort cream for day and night.
Scalp Comfort EssenceRole of SH50: scalp hydration and fermentable-sugar care in a leave-on water-based formula.Pair with: niacinamide, caffeine, gentle soothing agents.Positioning: a light, leave-on scalp treatment. Hydrating Repair Hair MaskRole of SH50: replenishing fiber moisture in an intensive rinse-off base.Pair with: cationic conditioners, hydrolyzed proteins, plant oils.Positioning: a weekly deep-hydration treatment.

These concepts are starting points for development discussions; suggested dosages remain within the reported cosmetic use concentrations for saccharide hydrolysate.

14 · SUMMARY · 核心总结

Why PuriActives® SH50

01 Advanced water management. A low-molecular-weight saccharide humectant system that binds water through dense hydroxyl chemistry and keeps it in the stratum corneum.

02 Barrier support. Hydration is structural: adequate water content supports desquamation, surface cohesion, and controlled water loss.

03 Consumer-perceivable comfort. Softer touch, smoother surface, less tightness — the sensory signature of hydrated skin and hair.

04 Skin + hair in one. One INCI, two categories: the same water-binding logic serves facial, body, scalp, and hair care.

05 Formulation-friendly. Simple water-phase addition, no format restrictions, globally compliant — CIR assessed safe as used, FDA GRAS background, listed in China IECIC.

What it is — a purified saccharide system · Why it matters — water defines skin and hair quality · Why choose it — simple, safe, versatile

15 · EVIDENCE BASE · 证据基础

Scientific References

[1] Johnson W Jr, Bergfeld WF, Belsito DV, et al. Safety Assessment of Anhydrogalactose, Anhydroglucitol, Anhydroxylitol, Arabinose, Psicose, Saccharide Hydrolysate, and Saccharide Isomerate as Used in Cosmetics. Int. J. Toxicol. 2025; 44(4_suppl): 93S–120S. DOI: 10.1177/10915818251384580

[2] Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol. Ther. 2004; 17(Suppl. 1): 43–48. DOI: 10.1111/j.1396-0296.2004.04S1005.x

[3] Fowler JF Jr. Understanding the role of natural moisturizing factor in skin hydration. Pract. Dermatol. 2012; 9: 36–40.

[4] Verdier-Sévrain S, Bonté F. Skin hydration: a review on its molecular mechanisms. J. Cosmet. Dermatol. 2007; 6(2): 75–82. DOI: 10.1111/j.1473-2165.2007.00300.x

[5] Fluhr JW, Tfayli A, Darlenski R, et al. Glycerol and natural sugar-derived complex modulate differentially stratum corneum water-binding properties and structural parameters in an in vitro Raman-desorption model. J. Biophotonics 2023; 16(1): e202200201. DOI: 10.1002/jbio.202200201

[6] Gournay A, Navarro R, Mathieu J, Rivière M. Water retention of treated stratum corneum measured by a coupling method: thermal desorption–mass spectrometry. Int. J. Cosmet. Sci. 1995; 17(4): 165–172.

[7] Hong KB, et al. Changes in the diversity of human skin microbiota to cosmetic serum containing prebiotics: results from a randomized controlled trial. J. Pers. Med. 2020; 10(3): 91. DOI: 10.3390/jpm10030091

[8] Berardesca E, Abril E, Serio M, Cameli N. Effects of topical gluco-oligosaccharide and collagen tripeptide F in the treatment of sensitive atopic skin. Int. J. Cosmet. Sci. 2009; 31(4): 271–277. DOI: 10.1111/j.1468-2494.2009.00495.x

[9] Le Bourgot C, Meunier C, Gaio E, et al. Effects of short chain fructo-oligosaccharides on selected skin bacteria. Sci. Rep. 2022; 12: 9702. DOI: 10.1038/s41598-022-13093-5

[10] Petrov A, Ćorović M, Milivojević A, et al. Prebiotic effect of galacto-oligosaccharides on the skin microbiota and determination of their diffusion properties. Int. J. Cosmet. Sci. 2022; 44(3): 309–319. DOI: 10.1111/ics.12778

[11] Zeng M, Li Y, Cheng J, Wang J, Liu Q. Prebiotic oligosaccharides in skin health: benefits, mechanisms, and cosmetic applications. Antioxidants 2025; 14(6): 754. DOI: 10.3390/antiox14060754

[12] Yu Y, Yang W, Wang B, Meyers MA. Structure and mechanical behavior of human hair. Mater. Sci. Eng. C 2017; 73: 152–163. DOI: 10.1016/j.msec.2016.12.008

[13] Wortmann FJ, Stapels M, Chandra L. Humidity-dependent bending recovery and relaxation of human hair. J. Appl. Polym. Sci. 2009; 113(5): 3336–3344. DOI: 10.1002/app.30336

[14] Robbins CR. Chemical and Physical Behavior of Human Hair. 5th ed. Berlin: Springer; 2012.

[15] Kanlayavattanakul M, Lourith N. Biopolysaccharides for skin hydrating cosmetics. In: Polysaccharides. Cham: Springer; 2015. p. 1867–1892. DOI: 10.1007/978-3-319-16298-0_29

Disclaimer

This document is prepared by PuriPharm Co., Ltd. for technical communication on cosmetic ingredients only and does not constitute any drug or medical claim. Third-party literature data are cited as technical background; the cited studies evaluated saccharide systems of the same class as, but not identical with, this product. Customers should independently verify the suitability and regulatory compliance of their finished formulations. PuriActives® is a trademark of PuriPharm Co., Ltd.

PURIPHARM CO., LTD.

PuriActives® SH50

Smarter sugar science for modern beauty — skin & hair hydration, from molecule to market.

INCI — SACCHARIDE HYDROLYSATE · CAS 8013-17-0

PuriPharm Co., Ltd. — Technical Product Report

OleaXin™ Oleanolic Acid Nanogel

PURIPHARM CO., LTD. · PuriActives® High-Performance Actives

OleaXin™ Oleanolic Acid Nanogel

齐肤因™ · Oleanolic Acid Nanogel

From a high-potential pentacyclic triterpene to a modern Nanogel active system.

INCI: Oleanolic Acid · Phospholipids · Glycerin · Water

Technical Marketing Presentation · For B2B Professional Use Only

01 · THE OPPORTUNITY

Why Refocus on Oleanolic Acid?

01 A Multi-Target Biological Foundation

Sebum regulation · inflammatory signaling · oxidative stress · ECM homeostasis · follicular microenvironment. Oleanolic acid is a pentacyclic triterpene widely found in olive, Ligustrum lucidum, and other plants, long followed by dermatological literature. Its value lies not in a single benefit, but in simultaneously touching multiple biological pathways related to oily skin, blemish-prone skin, and scalp health.

02 Skin + Scalp Dual Scenarios

Facial oil control and soothing share one mechanistic framework with scalp oil management.

03 A Deep Literature and Patent Base

From enzymology and cell studies to animal and human research, the evidence chain spans more than two decades.

04 Aligned with Oily-Skin and Scalp-Care Trends

Blemish-prone skin management, scalp microbiome care, and the “skinification” of hair care continue to gain momentum.

The scientific potential is high, yet formulation use is anything but simple — its highly lipophilic molecular nature has kept oleanolic acid a “research hotspot” rather than a “formulation regular.”

02 · MOLECULAR IDENTITY

Meet Oleanolic Acid: A Classic Pentacyclic Triterpene

Naming note: “石竹素” is the Chinese inventory name of Oleanolic Acid in China’s cosmetic ingredient system; the scientific narrative uses “齐墩果酸” (oleanolic acid), the name familiar to R&D professionals. Official ingredient information follows the INCI name.

INCI name Oleanolic Acid
Chinese inventory name 石竹素 (Inventory of Existing Cosmetic Ingredients in China)
CAS number 508-02-1
Formula / MW C₃₀H₄₈O₃ / 456.70 g·mol⁻¹
Chemical class Pentacyclic triterpene (β-amyrin type)
Natural sources Olive leaves, Ligustrum lucidum, Centella asiatica, and other plants
Physicochemical profile Highly lipophilic; practically insoluble in water

A molecule studied for over half a century — as one of the active components of many medicinal plants, its anti-inflammatory, antioxidant, and metabolism-modulating activities have been repeatedly reported in pharmacological literature, and its skin and scalp biology value continues to be rediscovered.

References: Ayeleso TB et al. Molecules. 2017;22(11):1915. DOI:10.3390/molecules22111915; PubChem CID 10494.

03 · THE FORMULATION CHALLENGE

High Bioactivity Does Not Mean High Formulation Usability

Practical Impact for Formulators

Difficult to dose directly into water-based serums and gels, requiring pre-dissolving or solubilization design; crystallization causes non-uniform content, affecting batch stability and efficacy consistency; high-ethanol / high-oil solubilization limits sensory feel and dosage-form options; the active’s theoretical efficacy is hard to convert reliably into finished-product performance.

The Industry Recognized This Long Ago

As early as 2001, an international cosmetics group filed a patent around “solubilizing pentacyclic triterpenic acids” (US 2001/0029266 A1), improving dispersion through specific emulsifier systems. Review literature likewise notes that oleanolic acid’s low water solubility limits its bioavailability, with structural modification and delivery systems as the two solution paths.

Solving the formulation bottleneck matters more than discovering yet another benefit — this is exactly where OleaXin™ starts.

References: US 2001/0029266 A1; Wang W et al. Curr Top Med Chem. 2022;22(1). DOI:10.2174/1568026621666211105101231.

04 · THE SOLUTION

PuriActives® OleaXin™ — Rebuilding Oleanolic Acid as a Nanogel

OleaXin™ converts highly lipophilic oleanolic acid, through phospholipid association and nanostructured dispersion, into a Nanogel active format compatible with aqueous systems — without changing the molecule itself, only the way it exists in a formula.

INCI NAMEOleanolic Acid 石竹素Phospholipids 磷脂 · Glycerin 甘油 · Water 水 DESIGN LOGICOleanolic acid + phospholipids + glycerin + water→ Nanogel Delivery System
a. Nanostructured deliveryNanostructured presentation of a lipophilic active b. Aqueous compatibilityAqueous-compatible format for modern chassis
c. Formulation-friendly dispersionImproved dispersion, fewer pre-dissolving steps d. Skin & scalp versatilityOne active for both skin and scalp care

齐肤因™ is the Chinese product name of PuriActives® OleaXin™. This material is for cosmetic ingredient technical exchange only and involves no pharmaceutical claims.

05 · DELIVERY ENGINEERING

From Crystalline Active to Nanogel: An Engineered Pathway

What It Means at the Formulation Level

· Improved aqueous dispersion · Lower crystallization risk · Simpler pre-dissolving · Broader dosage-form options · Better formula uniformity

Core conversion logic: Hard-to-Formulate Bioactive ——→ Ready-to-Use Advanced Active

Technical note: this page illustrates the delivery system design principle. OleaXin™’s specific particle size, encapsulation efficiency, and penetration data are subject to measured values in the PuriPharm TDS; without cited measured data, this material does not use statements such as “penetration increased by XX%.”

06 · BIOLOGICAL LANDSCAPE

One Active, Multiple Skin and Scalp Biology Pathways

The pentacyclic triterpene scaffold determines oleanolic acid’s potential to interact with multiple cellular signaling pathways. The following chapters unfold in the order of mechanism → data → biological significance → cosmetic value, each pathway annotated with traceable literature or patent evidence and its evidence level.

07 · SEBUM REGULATION

Oil Balance: Starting from Sebaceous Gland Biology

Sebum secretion is governed by androgen signaling: testosterone is converted by 5α-reductase into the more potent DHT, driving sebaceous gland hyperplasia and lipid synthesis. 5α-reductase is therefore a classic target for oil-control actives.

Human Efficacy Reference: An Oleanolic Acid-Containing Blend

28-day half-face controlled use test (3% blend, n≈20, oily-skin panel); multi-ingredient system, not attributable to oleanolic acid alone.

-21.7%skin gloss (mean) -16%pore surface area (mean) -32%sebum flow (mean)

Reading the Evidence

· Oleanolic acid’s 5α-reductase inhibition is direct in-vitro enzymatic evidence (patent assay data);· The human data come from a multi-ingredient blend containing oleanolic acid, indicating the mechanism’s market translation value;· Sebum management should also address inflammation and oxidative stress (next page).

Data sources: US 7,182,963 B2 (in-vitro 5α-reductase enzymatic assay); attached technical documentation (28-day human test of an oleanolic acid-containing blend).

08 · BLEMISH-PRONE SKIN

Blemish-Prone Skin Is Not a Single-Pathway Problem

Blemish formation involves the interplay of excess sebum, abnormal follicular duct keratinization, the microbial environment, and inflammatory responses. Oleanolic acid’s value lies in evidence covering several of these links — not merely “antibacterial anti-acne.”

① Sebum secretion5α-reductase / androgen-driven lipid synthesis ② Follicular environmentDuct keratinization and sebum retention form the comedone microenvironment ③ Microbial factorsCutibacterium acnes-related flora environment ④ Inflammatory responseNF-κB-driven redness and discomfort

Where Oleanolic Acid’s Evidence Sits in Each Link

■ Sebum link Concentration-dependent 5α-reductase inhibition (56.3% at 0.1%, in-vitro enzymatic assay)■ Microbial link Patent literature reports inhibitory activity against C. acnes and other skin-related flora■ Inflammation link Modulates NF-κB / STAT1 signaling in keratinocytes and animal models (detailed next page)■ Barrier link Promotes epidermal differentiation and barrier recovery, helping blemish-prone skin maintain a more stable state

Translated into Cosmetic Language

· Oily and blemish-prone skin care · Sebum balance management · Pore oil-environment management · Soothing discomfort of blemish-prone skinNo pharmaceutical claims such as “treating acne”; mechanistic evidence supports the product’s scientific narrative.

References: US 7,182,963 B2; Kang YM et al. Int J Mol Sci. 2021;22:12000; Lim SW et al. J Dermatol. 2007;34:625-634.

09 · INFLAMMATORY BALANCE

Stabilizing Stressed Skin from the Source of Inflammatory Signaling

Mechanistic Evidence: Cell and Animal Levels Corroborate Each Other

In vitro (HaCaT keratinocytes) Under TNF-α / IFN-γ stimulation, oleanolic acid blocked the activation of Akt, NF-κB, and STAT1, and suppressed Th2-type cytokine and chemokine expression.

In vivo (DNCB mouse model) Three weeks of topical dosing significantly relieved dermatitis-like lesions, reducing epidermal/dermal thickness, mast cell infiltration, and serum histamine levels.

Cosmetic value Helps soothe irritated skin · Maintains a healthy inflammatory balance · Improves skin comfort under stressful environments

Data source: Kang YM et al. Int J Mol Sci. 2021;22(21):12000. DOI:10.3390/ijms222112000 (animal and cell evidence, not human clinical conclusions).

10 · OXIDATIVE STRESS DEFENSE

Helping Skin Build Stronger Stress Defense

An Honest Scientific Positioning: It Is Not a Classic “Antioxidant”

DPPH radical-scavenging assays show oleanolic acid’s direct scavenging capacity is weak (only 9.2% at 100 µM, roughly equivalent to 4.45 µM Trolox). Its value lies in another path: pharmacological research links the oleanolic acid scaffold to the Keap1 / Nrf2 endogenous defense system and downstream antioxidant enzymes (HO-1, NQO-1), and it reduces oxidative stress markers in inflammation models.

Cell Compatibility: Evidence in Human Skin Fibroblasts

24-hour cytotoxicity assay: oleanolic acid (OA) showed no cytotoxicity up to 100 µM; its isomer ursolic acid (UA) had an IC₅₀ of 47.5 µM (MTT). OA is the gentler triterpene choice.

Cosmetic value Supports the cell’s endogenous defense against environmental stress · Helps maintain a more stable skin state

Data sources: Wójciak-Kosior M et al. Folia Histochem Cytobiol. 2011;49(4):664-669. DOI:10.5603/FHC.2011.0050; Wang W et al. Curr Top Med Chem. 2022;22(1).

11 · EPIDERMAL HOMEOSTASIS

Epidermal Homeostasis: Experimental Evidence for Barrier Resilience

Mechanistic Landing Point: PPAR-α and Epidermal Differentiation Markers

In HaCaT keratinocytes, oleanolic acid (10 µmol/L, 24 h) raised PPAR-α, involucrin, loricrin, and filaggrin protein expression to about 2× control; electron microscopy showed increased lamellar body secretion and more complete lipid bilayer formation.

Cosmetic value Supports epidermal homeostasis and barrier resilience · Helps maintain healthy skin barrier function · Completes the oily-skin care logic together with oil control and soothing

Data source: Lim SW et al. J Dermatol. 2007;34(8):625-634. DOI:10.1111/j.1346-8138.2007.00344.x (animal and cell evidence).

12 · MATRIX PROTECTION

Guarding the ECM: From Oxidative Stress to Collagen Degradation

▲ Oleanolic acid’s known evidence sits at upstream nodes: modulating oxidative stress and inflammatory signaling (NF-κB / MAPK family), influencing the matrix degradation cascade from its source.

ECM-Related Evidence Leads

■ Delivery + collagen patent An oleanolic acid liposome composition patent (CN 103221028 B) targets collagen production, showing that “delivery technology + ECM” is an industry-recognized R&D path■ Photoaging use patent A composition patent for pentacyclic triterpenic acids in preventing photoaging and sensitive skin (US 2001/0029266 A1)■ Mechanistic level MAPK / NF-κB modulation evidence (see the inflammation chapter) covers upstream MMP signaling

Evidence Boundary Statement

Current ECM-related evidence for oleanolic acid consists mainly of patents and mechanistic studies; human anti-wrinkle clinical data are still lacking. This material therefore avoids statements like “reduces wrinkles by XX%” and instead positions oleanolic acid as an upstream modulator of the oxidative stress – inflammation – matrix degradation cascade.

Cosmetic value Supports ECM homeostasis · Helps reduce stress-induced matrix degradation · Maintains a collagen-rich skin structure · Supports skin elasticity and firmness

References: CN 103221028 B; US 2001/0029266 A1; Kang YM et al. Int J Mol Sci. 2021;22:12000 (patent- and mechanism-level evidence).

PART II · SCALP SCIENCE

Skin biology doesn’t stop at the hairline.

From skin to scalp — shared sebum, inflammation, and oxidative stress biology.

The scalp is an extension of the skin: dense sebaceous glands, dense follicles, and androgen sensitivity. The mechanistic evidence for oleanolic acid in facial sebum management applies equally to the scalp scenario.

13 · SCALP & ANDROGEN BIOLOGY

Scalp Oil and Androgen Biology: Same Target, Second Scenario

Recalling the page-8 data: oleanolic acid concentration-dependently inhibits 5α-reductase in vitro (56.3% inhibition at 0.1%, US 7,182,963 B2) — a mechanism pointing to both facial sebum and scalp oil scenarios.

What Makes the Scalp Scenario Special

· High sebaceous gland density: oil oxidation products and flora metabolites together form an irritation source· Follicles are sensitive to androgen signaling; DHT-related follicular microenvironment stress is a focus of hair-care research· Scalp care is shifting from “hair-fiber cosmetic finish” to “scalp ecology management”

Compliant Cosmetic Language

· Helps maintain a healthy scalp oil environment · Supports scalp ecological balance · Helps maintain a healthy follicular microenvironment · Supports scalp and follicle vitalityNo “anti-hair-loss / hair-growth / hair-loss treatment” claims.

References: US 7,182,963 B2; WO 2017/021247 A1 (hair-care composition patent containing oleanolic acid blends).

14 · FOLLICULAR MICROENVIRONMENT

The Follicular Microenvironment: More Than Just “Oil Control”

A 6-month open human study (56 subjects with androgenetic alopecia and telogen effluvium) showed that a scalp lotion containing oleanolic acid, apigenin, biotinyl tripeptide-1, and other ingredients significantly increased total hair count and anagen hair count. Oleanolic acid plays the 5α-reductase-modulating role in the blend.

Dermatologist Assessment (D180, full sample)

35.7%hair felt denser and fuller 37.5%overall hair appearance improved 39.3%scalp coverage improved

Reading the Evidence

· Human data from a multi-ingredient blend cannot be attributed to oleanolic acid alone;· Yet it is directionally consistent with the in-vitro 5α-reductase evidence, forming a “mechanism + clinical signal” combination;· No adverse events were reported throughout, with favorable usability ratings.

Cosmetic narrative: balanced scalp oil → a healthier follicular environment → support for hair vitality. Focus on “scalp care,” not “hair-loss treatment.”

Data source: Garre A et al. J Cosmo Trichol. 2018;4(1):1000132. DOI:10.4172/2471-9323.1000132 (multi-ingredient blend, 6-month open study).

15 · WHY NANOGEL MATTERS

Why Does Nanogel Matter So Much for Oleanolic Acid?

Conventional Oleanolic Acid (Crystalline Raw Material) PuriActives® OleaXin™ (Nanogel Active System)
Poor compatibility with aqueous systems Aqueous-compatible Nanogel format
Hard to disperse; requires pre-dissolving / solubilization design Improved dispersion; more direct dosing
Crystallization / precipitation risk Nanostructured presentation lowers recrystallization tendency
Limited dosage-form and formulation freedom Greater formulation flexibility (serum / gel / emulsion / scalp essence)
A conventional active format A delivery-enabled active for modern formulations

Each comparison dimension corresponds to verifiable technical basis: oleanolic acid’s lipophilicity and solubilization difficulty are documented in literature and patents (US 2001/0029266 A1; Wang et al. 2022); Nanogel-side statements describe delivery system design characteristics, with specific parameters subject to measured values in the PuriPharm TDS.

16 · FORMULATOR VALUE

What Does It Mean for Formulators?

  • A more convenient way to use oleanolic acid No need to solve solubilization from scratch; the active is dosed directly in water-dispersible form
  • Greater formulation freedom Less reliance on high-ethanol or high-oil solubilization
  • Compatible with modern water-based serum systems Works in serums, gels, emulsions, and other mainstream formats
  • Skin Care + Scalp Care dual scenarios One active covers both facial and scalp product lines
  • Fewer complex pre-dissolving steps Shorter process chain and lower batch-to-batch content-variation risk
  • An easy nano-technology product story The Nanogel delivery narrative combines scientific credibility with market recognition
  • Supports lightweight dosage forms Matches the “fresh, non-greasy feel” brief of oily-skin care

Hard-to-Formulate Bioactive → Ready-to-Use Advanced Active

17 · APPLICATIONS — SKIN CARE

Skincare Applications: Every Direction Has a Biological Basis

Sebum balance serum 5α-reductase modulation acting on upstream sebum-signaling (in-vitro enzymatic evidence)
Blemish-care serum Multi-link support across sebum + microbial environment + inflammatory signaling (in-vitro / animal evidence)
Lightweight oil-control moisturizer Aqueous-compatible Nanogel format suits fresh, light-feel systems (delivery system design feature)
Soothing serum NF-κB / STAT1 inflammatory-signal modulation improves comfort under stress (animal + cell evidence)
Antioxidant defense serum Supports endogenous defense pathways rather than relying on direct radical scavenging (mechanism-level evidence)
Anti-aging direction serum Upstream modulation of the oxidative stress – inflammation – matrix degradation cascade (patent and mechanistic evidence)
Urban stress protection Dual oxidative + inflammatory stress management for UV / pollution scenarios (mechanism-level evidence)

Application directions are development suggestions; specific efficacy claims must be based on finished-formula efficacy evaluations; evidence levels are annotated in each row.

18 · APPLICATIONS — SCALP CARE

Scalp-Care Applications: A Scalp-First Formulation Mindset

From “smoothing the hair fiber” to managing scalp ecology — this is the upgrade direction the scalp-care category is undergoing.

Scalp balance serum Scalp sebum modulation and oil-environment management (supported by in-vitro 5α-reductase evidence)
Oil-control scalp serum A fresh, water-based-compatible formula for oily scalps
Leave-on scalp lotion A leave-on format covering follicular microenvironment management
Soothing scalp care Inflammatory-signal modulation to help relieve scalp discomfort (animal + cell evidence)
Hair vitality essence Follicular microenvironment + oxidative stress management supporting a healthy hair-growth environment (multi-ingredient clinical signal)
Anti-grease scalp care Daily management of scalp oil oxidation and the flora environment

Compliance note: scalp applications focus on “scalp care” and the “hair vitality environment”; no anti-hair-loss, hair-growth, or hair-loss-treatment claims; multi-ingredient human study data serve only as directional mechanistic reference.

19 · CONCEPT SHOWCASE

Product Concept Examples

OleaXin™ Sebum Reset Serum

Sebum regulation + inflammatory balance + oxidative defense — a daily management serum for oily skin

OleaXin™ Clear Balance Essence

Environment management for blemish-prone skin: sebum balance + microbial environment + soothing

OleaXin™ Matrix Defense Serum

Upstream defense against oxidative stress and the matrix degradation cascade — anti-aging direction

OleaXin™ Scalp Balance Serum

A scalp-balancing serum covering scalp sebum + soothing + follicular microenvironment

OleaXin™ Follicular Vitality Essence

A leave-on scalp essence for oxidative stress + follicular environment + scalp vitality

Concept Design Principles

· Each concept maps to a defined combination of biological targets, not a pile-up of claims;· Concepts are development-direction examples only and contain no experimentally unverified formula ratios;· For use levels, compatibility, and stability data, refer to the PuriPharm TDS and formulation guide;· Finished-product efficacy claims are subject to the final product’s efficacy evaluation.

20 · VALUE SUMMARY

OleaXin™ Core Value: Three Pillars

PILLAR IMultifunctional Biology PILLAR IIAdvanced Delivery PILLAR IIIFormulation Value
Sebum regulation · inflammatory balanceOxidative stress defense · ECM protectionEpidermal homeostasis · scalp homeostasisA multi-target evidence chain, from in-vitro enzymology to human study signals Phospholipid Nanogel delivery systemNanostructured presentationAqueous-system compatibilityChanging how the active exists in a formula, not the molecule itself Flexible formats · easy dosingSkin & scalp dual-scenario coverageA nano-technology product narrativeFrom hard-to-formulate bioactive to ready-to-use advanced active

Bringing the scientific potential of oleanolic acid into modern formulations.UNLOCKING THE COSMETIC POTENTIAL OF OLEANOLIC ACID

21 · SELECTED REFERENCES

Key References and Patents

Peer-Reviewed Papers

[1] Kang YM, Kim HM, Lee M, An HJ. Oleanolic Acid Alleviates Atopic Dermatitis-like Responses In Vivo and In Vitro. Int J Mol Sci. 2021;22(21):12000. DOI:10.3390/ijms222112000[2] Lim SW, Hong SP, Jeong SW, et al. Simultaneous effect of ursolic acid and oleanolic acid on epidermal permeability barrier function and epidermal keratinocyte differentiation via PPAR-α. J Dermatol. 2007;34(8):625-634. DOI:10.1111/j.1346-8138.2007.00344.x[3] Wójciak-Kosior M, Paduch R, Matysik-Woźniak A, et al. The effect of ursolic and oleanolic acids on human skin fibroblast cells. Folia Histochem Cytobiol. 2011;49(4):664-669. DOI:10.5603/FHC.2011.0050[4] Garre A, Piquero J, Trullas C, Martinez G. Efficacy and Safety of a New Topical Hair Loss-Lotion Containing Oleanolic Acid, Apigenin, Biotinyl Tripeptide-1, Diaminopyrimidine Oxide, Adenosine, Biotin and Ginkgo biloba. J Cosmo Trichol. 2018;4(1):1000132. DOI:10.4172/2471-9323.1000132 (multi-ingredient blend)[5] Ayeleso TB, Matumba MG, Mukwevho E. Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases. Molecules. 2017;22(11):1915. DOI:10.3390/molecules22111915[6] Wang W, Li Y, Li Y, et al. Oleanolic Acid: Structural Modification and Biological Activities. Curr Top Med Chem. 2022;22(1). DOI:10.2174/1568026621666211105101231

Patents and Technical Documentation

[7] US 7,182,963 B2. Cosmetic and dermopharmaceutical compositions for skin prone to acne (contains in-vitro 5α-reductase enzymatic data for oleanolic acid; family: US 2006/0239957 A1)[8] US 2001/0029266 A1. Composition containing a pentacyclic triterpenic acid (solubilization of pentacyclic triterpenic acids)[9] WO 2017/021247 A1. Anti-hair loss lotion (hair-care composition containing oleanolic acid blends)[10] CN 103221028 B. Oleanolic acid liposome composition (collagen direction)[11] CN 103648502 B. Anti-inflammatory use of oleanolic acid acetate[12] Attached technical documentation: 28-day human efficacy test of an oleanolic acid-containing blend (gloss / pores / sebum flow, n≈20)

Disclaimer

This material is prepared by PuriPharm Co., Ltd. for cosmetic ingredient technical exchange only and constitutes no pharmaceutical or medical claims. In-vitro / animal study data do not represent finished-product human efficacy; third-party literature and patent data are cited as technical background only. Customers should independently verify the suitability and regulatory compliance of their finished formulations. PuriActives® and OleaXin™ are trademarks of PuriPharm Co., Ltd.

PuriPharm Co., Ltd. · www.puriactives.com · service@puripharm.com

PuriActives® BioFuco™ Powder

PuriActives® BioFuco™ Powder

A Microbiome-Friendly Prebiotic Powder Blend

A tri-saccharide system for skin and scalp microbiome balance

INCI: Biosaccharide Gum-1 · Xylitol · Lactitol

Microbiome balance · Barrier & hydration · Smart powder format

Product Technology & Market Introduction · Cosmetic Active Ingredient

01 · SKIN ECOLOGY

The Next Logic of Skincare: Skin Is an Ecosystem

Skin is more than a physical barrier — it is an ecosystem built by microorganisms, sebum, water, and immune cells together. Resident flora occupy ecological niches, produce antimicrobial molecules, and “educate” the immune system: they are the first “living line of defense” of skin homeostasis.

When the flora falls out of balance (dysbiosis), dryness, sensitivity, breakouts, and dandruff follow — the answer is to restore balance, not to eliminate indiscriminately.

Dryness & flaking · Sensitivity & redness · Breakouts · Dandruff— all are scientifically linked to microbiome imbalance

106microorganisms / cm²Order of magnitude of microbial density on healthy skin ≈1,000bacterial species identified on human skinDiversity is closely tied to skin health

Sources: Grice & Segre, Nat Rev Microbiol, 2011; Byrd et al., Nat Rev Microbiol, 2018.

02 · WHY THE MICROBIOME

From “Killing” to “Nurturing”: The Shift Toward Microbiome Balance

Traditional Antimicrobial Logic|KILL THEM ALL

Broad-spectrum antimicrobials remove microbes indiscriminately; resident and pathogenic flora are damaged alike; the ecological vacuum lets pathogens rebound faster; barrier and flora homeostasis are repeatedly disrupted.

Microbiome Balance Logic|BALANCE THE ECOSYSTEM

Provide sugar substrates usable by resident flora; selectively limit pathogen adhesion and biofilms; restore the natural balance of niche competition; a better microenvironment builds a stronger barrier.

Sources: Byrd et al., Nat Rev Microbiol, 2018; Katsuyama et al., J Dermatol Sci, 2005.

03 · PRODUCT CONCEPT

BioFuco™ Powder: A Tri-Saccharide Prebiotic Active

Biosaccharide Gum-1|A Fucose-Rich Polysaccharide

A fermentation-derived polysaccharide. Film-forming water lock for lasting hydration; soothing and skin-friendly with high skin affinity; enhances formulation sensory feel.

Xylitol|A Prebiotic Five-Carbon Sugar Alcohol

A prebiotic pentitol. A selective substrate for resident flora; upregulates filaggrin to support the barrier; limits pathogen adhesion and biofilm formation.

Lactitol|A Prebiotic Disaccharide Alcohol

A prebiotic disaccharide polyol. Selectively utilized by beneficial bacteria; a multi-hydroxyl hydrating structure; improves scalp and skin comfort.

Polysaccharide network × prebiotic sugar alcohols × microbiome modulation — not a simple blend, but a synergistic active system designed around the skin ecosystem.

PositioningMicrobiome-friendly activePrebiotic skin-conditioning system Technical ProfileFermentation biotechnologyPreservative-free powder

04 · SYNERGY SYSTEM

The Tri-Saccharide System: One Synergistic Eco-Active

Microbiome Modulation

Selectively feeds resident flora while restraining opportunistic pathogens.

Barrier Support

Xylitol upregulates filaggrin and reduces TEWL.

Lasting Hydration

Film-forming + humectant sugars + endogenous NMF.

Soothing Comfort

The fucose-rich polysaccharide soothes sensitive, reactive skin.

The synergy logic is based on published research evidence for each component; see the evidence page and source notes.

05 · PREBIOTIC MODULATION

Selective Prebiotics: Feed the Residents, Restrain the Opportunists

Staphylococcus epidermidis

Resident flora · produces antimicrobial peptides · maintains homeostasis

1% xylitol significantly promotes growth; higher growth rate in pure culture (p < 0.001).

Staphylococcus aureus

Opportunistic pathogen · linked to atopic skin concerns · can form biofilms

5% xylitol significantly inhibits growth; growth suppressed in pure culture (p < 0.001).

Cutibacterium acnes

Common in sebum-rich areas · overgrowth linked to breakouts

5% xylitol significantly inhibits growth; both tested strains suppressed (p < 0.005–0.001).

Mechanism: xylitol is difficult for opportunistic pathogens such as S. aureus to ferment, yet can be metabolized by specific resident flora; it also inhibits S. aureus glycocalyx synthesis and biofilm formation — the essential difference between prebiotic modulation and broad-spectrum antimicrobial action. Lactitol is likewise selectively utilized by beneficial bacteria in microbiome models.

Sources: Anglenius et al., Korean J Microbiol, 2020 (in vitro, pure culture); Katsuyama et al., J Dermatol Sci, 2005; lactitol prebiotic evidence: Björklund et al., Age, 2012 (microbiome model).

06 · REBUILDING THE NICHE

Beyond Inhibition — Rebuilding a Resident-Dominated Niche

Selectivity Is Clear

The combination inhibits biofilm formation by opportunistic S. aureus by up to 64.7%, while affecting resident S. epidermidis by only < 2.5%.

Co-Culture Confirmation

The system reversed the growth advantage of S. aureus, restoring dominance to S. epidermidis — niche competition shifted back toward health.

In-Vivo Echo

A xylitol-containing cream applied to atopic dry skin significantly reduced S. aureus colonization and improved dryness within 4 weeks.

Source: Katsuyama et al., J Dermatol Sci, 2005 (Part 2, human study).

07 · SKIN BARRIER

Microbiome → Barrier → Skin Resilience

Human evidence: barrier support (14 days, n = 12, dry skin).

TEWL ↓TEWL significantly reduced; barrier function improved Filaggrin ↑More filaggrin-positive epidermal cells (~25% vs. control) Hydration ↑Stratum corneum hydration and biomechanics improved together

A 5% glycerol + 5% xylitol formula used for 14 days: TEWL fell significantly while skin hydration, epidermal and dermal thickness, and the DEJ undulation index all rose; in-vitro data identify xylitol as the key component upregulating filaggrin expression.

In an SLS acute-irritation human model, xylitol and glycerol showed dose-dependent anti-irritant and anti-inflammatory effects — direct evidence for sensitive-skin and compromised-barrier scenarios.

Sources: Korponyai et al., Acta Derm Venereol, 2017 (in vivo); Szél et al., J Eur Acad Dermatol Venereol, 2015 (in vivo).

08 · HYDRATION

A Triple Hydration Mechanism: Film · Humectancy · NMF

8hBiosaccharide Gum-1 hydration lasts 8 hours in human testingIngredient technical dossier (in-vivo volunteer study)

01 Film-Forming — a “Breathable Moisture Film”

The high-molecular-weight polysaccharide forms a non-occlusive moisturizing film on the skin surface, slowing water loss for immediate and long-lasting hydration with a silky, non-sticky feel.

02 Humectancy — Hydrogen-Bond “Water Capture”

The multi-hydroxyl structures of xylitol and lactitol bind water molecules through hydrogen bonds, raising stratum corneum water content and maintaining dynamic moisture balance even in dry environments.

03 Endogenous NMF — Upregulating Filaggrin

Xylitol upregulates filaggrin expression in keratinocytes — filaggrin breakdown products are the primary source of natural moisturizing factor (NMF), reinforcing hydration from within rather than relying on external humectants alone.

Sources: Korponyai et al., Acta Derm Venereol, 2017; Cohen et al., J Chem Soc Faraday Trans, 1993; Biosaccharide Gum-1 ingredient technical dossier (in vivo).

09 · SOOTHING & COMFORT

The Skin-Friendly Science of a Fucose-Rich Polysaccharide

Fucose is a natural component of human glycoproteins and glycolipids — skin “recognizes” Biosaccharide Gum-1, which is naturally highly affine and highly tolerated.

This makes it a time-proven soothing ingredient for sensitive and reactive skin care.

Sources: Biosaccharide Gum-1 ingredient technical dossier (in-vivo volunteer testing); Szél et al., J Eur Acad Dermatol Venereol, 2015 (in vivo); CIR Expert Panel safety assessment of microbial polysaccharide gums.

PART II · THE SMART POWDER FORMAT

From Liquid Actives to a Smart Powder

A more stable, more convenient, more efficient delivery form for a microbiome active

10 · WHY POWDER

Why a Powder: Five Pain Points of Liquid Actives, Solved One by One

Preservative-Free Format

Low water activity inhibits microbial growth, reducing reliance on preservatives.

Easy to Store

A solid form — simply sealed at room temperature; stable in long-term inventory.

Easy to Ship

Over 95% of water weight removed; built for global supply chains.

Easy to Handle

Free-flowing and non-caking; convenient to weigh and dose in both lab and production.

Easy to Disperse

Disperses quickly and evenly in the water phase; suitable for transparent formulas as well.

Traditional Liquid Actives BIOFUCO™ POWDER
~97% water · requires a preservation system Solid composite powder · low water activity by design
Heavy to ship · shelf life challenged by microbes Light to ship · storage-friendly · flexible supply chain
Low-dose actives are hard to weigh precisely Solid dilution ensures weighing and dispersion accuracy

The format comparison is based on the typical ~97% water content of liquid products in public technical literature; actual formulation performance should be verified.

11 · SMART SOLID DILUTION

Smart Solid Dilution: Every Milligram Under Precise Control

What It Means for Formulators

  • Accurate dosing: gram-scale handling with milligram-level precision.
  • Uniform dispersion: no local concentration spikes.
  • Non-caking: free-flowing and disperses instantly in water.
  • Scalable dosing: seamless scale-up from lab to production.
  • Standardized delivery: consistent active content from batch to batch.
  • High efficacy at low dose: a 1%–2% reference use level delivers the designed activity.

Use levels are reference ranges and should be optimized against formulation goals; the solid dilution process is a product design description.

12 · SCALP MICROBIOME

The Scalp: An Ecosystem That Also Needs Balance

The microbial fingerprint of dandruff: lipophilic Malassezia rises from 46% to 74%–83%, while resident C. acnes falls from 26% to single digits — dandruff is fundamentally a flora-imbalance problem.

The cascade of imbalance: dysbiosis accompanies elevated TEWL and pH plus a compromised scalp barrier, leading to dryness, itching, flaking, and scalp sensitivity.

A new care target: maintain scalp flora homeostasis and nourish the resident ecology — the next generation of scalp care beyond “aggressive anti-dandruff.”

13 · SCALP EVIDENCE

Xylitol × Lactitol: Evidence for Scalp Hydration and Barrier

Study Design

28 volunteers (16 women / 12 men) used a xylitol–lactitol wash-and-care regimen 3 times over 10 days — shampoo 1% + conditioner 1% + leave-on product 2%, against a placebo control.

Results

Scalp hydration rose +27% immediately and held at +17% on day 10; TEWL improved by -12.7% (trend); video microscopy showed regulated desquamation and stronger scalp barrier integrity.

Implication

By restoring scalp ecological balance — feeding beneficial flora and restraining harmful flora — dryness, itching, and dandruff discomfort are relieved at the source.

14 · SKINCARE APPLICATIONS

Skincare Applications: From Concept to Everyday Formulas

Microbiome Concepts

Microbiome skincare serums · prebiotic / postbiotic creams · post-cleansing microbiome care · flora-balancing lotions

Targeted Care

Soothing care for sensitive skin · barrier-repair creams · long-lasting hydrating serums and masks · microbiome care for blemish-prone skin

Gentle Scenarios

Gentle baby and child care · hydrating soothing mists · cleansers and rinse-off products · after-sun repair gels

Positioning: a microbiome-friendly active · a prebiotic skin-conditioning systemSuitable for leave-on and rinse-off systems; the water-soluble powder fits serums, creams, masks, mists, and cleansers.

Whether for a new “flora balance” concept launch or a sensitive-skin formula that pairs soothing with barrier support, BioFuco™ Powder delivers a clear scientific narrative and formulator-friendliness through a concise INCI combination.

15 · HAIR & SCALP CARE

From Scalp Ecology to Hair Condition

Scalp MicrobiomeBalanced scalp flora Scalp BarrierScalp barrier integrity Comfort & HydrationComfort and moisture Healthy HairA healthy environment for hair

Typical Product Applications

  • Microbiome shampoos
  • Leave-on scalp serums
  • Soothing scalp mists
  • Conditioners and hair masks
  • Anti-dandruff support care
  • Products for sensitive scalps

Bonus: the film-forming property of Biosaccharide Gum-1 can remain on the hair fiber surface after rinsing, helping smooth the cuticle and enhance smoothness and shine (ingredient technical dossier).

16 · FORMULATOR-FRIENDLY

For Formulators: Usage Guide and Technical Notes

Item Recommendation
Reference use level 0.5%–2.0% (reference range; optimize per formulation goals and efficacy positioning)
Phase of addition Add to the water phase; ≤45°C for emulsion systems, room temperature for gels and aqueous systems
Dissolution & dispersion Sprinkle slowly into the water phase under stirring; disperses and dissolves within minutes; pre-disperse and sieve for transparent formulas
pH suitability 4.0–8.0 (reference range; suits mildly acidic to neutral systems)
Compatibility & compliance Good compatibility with common surfactants, thickeners, and preservation systems (reference); all three ingredients are IECIC-listed cosmetic raw materials; xylitol has been assessed by CIR

The above is a reference guide based on the ingredient’s public technical documentation and does not constitute precise process parameters; final formulation parameters should be confirmed through laboratory validation and stability testing.

17 · EVIDENCE CHAIN

The Evidence Chain: Mechanism → Evidence → Benefit

Mechanism Key Evidence (Source · Level) Cosmetic Benefit
Selective microbiome modulation 1% xylitol promotes S. epidermidis; 5% inhibits S. aureus / C. acnes — Anglenius et al., Korean J Microbiol, 2020 · in vitro Microbiome-friendly concept
Anti-biofilm & niche rebuilding Xylitol inhibits S. aureus glycocalyx and biofilms — Katsuyama et al., J Dermatol Sci, 2005 · in vitro + human; prebiotic blend inhibits S. aureus biofilms by up to 64.7% — Di Lodovico et al., Microorganisms, 2021 · in vitro Blemish-prone and sensitive skin care
Barrier strengthening Filaggrin expression up, TEWL significantly down (14 days, n=12) — Korponyai et al., Acta Derm Venereol, 2017 · human Barrier repair
Triple hydration Polysaccharide film hydrates for 8 hours — ingredient dossier · human; polyol hydrogen bonding to water — Cohen et al., 1993; filaggrin/NMF upregulation — Korponyai et al., 2017 Long-lasting hydration
Soothing & comfort Post-challenge volunteer testing confirms soothing — ingredient dossier · human; dose-dependent anti-irritation in the SLS model — Szél et al., JEADV, 2015 · human Sensitive-skin comfort
Scalp microbiome care Scalp hydration +27% (immediate) / +17% (day 10), TEWL -12.7% (day 10, n=28) — PCT/IB2004/004345 patent-family clinical data · human Scalp and hair care

In-vitro / dossier data ≠ finished-product clinical efficacy; third-party literature is for technical reference only and does not represent results for the BioFuco™ Powder finished formulation.

SUMMARY & CONTACT

Feed the beneficial flora. Balance the microbiome.

Microbiome BalanceFeed residents, restrain opportunists Barrier SupportFilaggrin · TEWL · NMF HydrationFilm + humectancy + NMF
Skin ComfortSoothing for sensitive skin Scalp CareBacked by clinical evidence Smart Powder FormatPreservative-free · easy to use

PuriActives® BioFuco™ Powder — the prebiotic powder for skin and scalp microbiome balance

PURIPHARM CO., LTD.

www.puriactives.com · service@puripharm.com · +86-572-2745768Building 6, No. 1366 Hongfeng Road, Huzhou, Zhejiang, China

This material is for cosmetic ingredient introduction only and does not constitute pharmaceutical claims; in-vitro and ingredient dossier data are not equivalent to finished-product clinical efficacy; cited third-party literature is for technical reference only. PuriActives® and BioFuco™ are trademarks of PURIPHARM CO., LTD.

PuriActives® ChitoQ

PuriActives® ChitoQ

INCI: Chitosan Hydroxypropyltrimonium Chloride

A permanently cationic chitosan derivative that delivers conditioning, moisturization, and antimicrobial support for skin and hair through a single bio-based polymer.

For cosmetic formulators · R&D scientists · Product development and brand innovation teams

01 · FORMULATION CHALLENGE

An excellent biopolymer constrained by pH

The limitation of native chitosan

  • Its amino-group charge exists only below pKa ≈ 6.3–6.5; above that range, both charge and solubility collapse.
  • It requires acidic systems, limiting dosage-form choices and active-ingredient combinations.
  • Its performance is weakest across the true pH range of skin and hair products (4.5–7).

New market requirements

  • Bio-based, biodegradable conditioning polymers.
  • Multifunctionality in one ingredient: conditioning + moisturization + microbial support.
  • Rinse-resistant deposition without build-up or tackiness.

Sources: chitosan pKa and pH-dependent charge—J. Mater. Chem. B 2023; ACS Appl. Mater. Interfaces 2023.

02 · PRODUCT OVERVIEW

One molecule, two care categories.

PuriActives® ChitoQ is a quaternized chitosan: a marine-derived polysaccharide carrying permanent quaternary ammonium groups. It is water-compatible, permanently cationic, and multifunctional for both leave-on and rinse-off systems.

  • Cationic affinity deposition on hair keratin and skin surfaces.
  • Conditioning, cuticle smoothing, and anti-static performance.
  • Moisturization benchmarked against hyaluronic acid.
  • Broad-spectrum antimicrobial and anti-biofilm support.
  • A bio-based, biodegradable alternative to synthetic polyquaterniums.

pH 3–10Maintains permanent cationic character across the formulation pH window 0.625 mg/mLMIC against Streptococcus mutans—90% growth inhibition in vitro
98.5%Degree of substitution in the current batch (specification ≥ 80%) CosIngEU-listed INCI—functions: hair conditioning and humectant

Sources: Gao et al., Molecules 2024 (S. mutans, in vitro); EU CosIng database; Puripharm batch COA (May 2026).

03 · MOLECULAR DESIGN

From chitosan to ChitoQ: functional quaternization

Permanent cationic charge

Quaternary ammonium groups never deprotonate, preserving charge across the full cosmetic pH range.

True water compatibility

It dissolves directly in water without acidification—add it to the water phase and formulate freely.

Stronger surface affinity

Electrostatic binding to anionic keratin and skin surfaces drives affinity deposition and film formation.

The quaternization route follows the published synthesis of N-2-hydroxypropyltrimethylammonium chloride chitosan (Gao et al., Molecules 2024).

04 · PHYSICOCHEMICAL PROPERTIES

Positive charge at any formulation pH

Unconditional charge

Quaternary ammonium groups remain protonated from acidic to weakly alkaline media—affinity deposition no longer depends on pH.

Soluble where chitosan is not

High-substitution HACC forms clear aqueous solutions (transmittance >80% at 80% substitution)—no acidification or pre-dissolution required.

Built for deposition

High permanent charge density maximizes electrostatic interaction with anionic keratin and skin—the physical basis for conditioning and film formation.

Sources: ACS Appl. Mater. Interfaces 2023 (zeta potential of quaternized chitosan, pH 3–10); ACS Omega 2021 (QCS charge retention); Gao et al., Molecules 2024 (solubility).

05 · MECHANISM OF ACTION

Designed to bind precisely where damage occurs

  1. Selective attraction: the isoelectric point of hair keratin is approximately 3.67. At cosmetic pH, hair carries a net negative charge, and damaged fibres are even more negatively charged.
  2. Cationic deposition: ChitoQ adsorbs to anionic sites through electrostatic interaction, concentrating deposition where the fibre needs it most and resisting rinse-off.
  3. Conditioning film: the bound polymer forms a smooth, hydrophilic film that lays cuticles flat, reduces friction and static, and helps retain surface moisture.

The same physical mechanism works on skin: an affinity, breathable cationic film binds water and supports the surface barrier—one mechanism, two categories.

Source: hair isoelectric point and cationic deposition mechanism—Gavazzoni Dias et al., On Hair Care Physicochemistry, Int. J. Trichology / PMC9921463.

EVIDENCE SECTION

Performance evidence

Quantified results from peer-reviewed research on ChitoQ chemistry, presented with transparent evidence grading.

A | Studies on ChitoQ chemistry itself (Chitosan Hydroxypropyltrimonium Chloride)

B | Structurally similar quaternized chitosan—mechanistic support

C | General chitosan literature—physicochemical background

06 · HAIR-CARE PERFORMANCE

Affinity conditioning beyond rinse-off

A cationic film restores surface smoothness and shine.

Targeted deposition on damaged keratin [B]

The affinity of quaternized chitosan for hair keratin has been demonstrated, and its strengthening and conditioning effects have been documented since the earliest quaternized-chitosan patents.

Easier wet and dry combing [C]

The adsorbed film reduces inter-fibre friction, helps detangling, and reduces mechanical breakage during combing.

Anti-static and frizz control [C]

Charge neutralization plus a smoothing film minimizes static and seals cuticles against humidity-induced frizz.

Shine, softness, and color protection [C]

Flat cuticles reflect light evenly, while the protective film helps color resist washing and UV exposure.

Added scalp-care benefit [A]

Demonstrated antimicrobial activity extends the benefit from the hair fibre to the scalp environment.

Damaged hair has a lower isoelectric point and a denser negative surface charge, so cationic polymers deposit preferentially where repair is most needed.

Sources: US 4,772,689 (Lang et al., quaternized-chitosan affinity); PCACD 2024 review (chitosan hair care); Gao et al., Molecules 2024. See the evidence section for [A]/[B]/[C] grading.

07 · SKIN-CARE PERFORMANCE

Hyaluronic-acid-level moisturization

[A] HACC performs within the hyaluronic-acid range, and its ion-exchange derivative can reach 2.2× HA. At 43% RH, the HACC derivative also absorbed more moisture than HA (74–94% vs 32.4%, 48 h).

Dual water management

A surface rich in hydroxyl and quaternary ammonium groups binds water through hydrogen bonding, while the affinity film helps slow transepidermal water loss. [A/C]

Breathable barrier support

Chitosan films are non-occlusive: they buffer the stratum corneum against environmental stress while allowing skin to function normally. [C]

Sensory differentiation

The cationic film provides a distinctive smooth, cushioned after-feel—a humectant consumers can actually perceive. [C]

Sources: Mi et al., Polymers 2021 (PMC8307204)—in vitro comparison of moisture absorption/retention by HACC, its derivatives, and sodium hyaluronate; chitosan film/TEWL literature (PCACD 2024).

08 · ANTIMICROBIAL SUPPORT

A cationic mechanism acting on microbial surfaces

0.625 mg/mLMIC of N-2-HACC against S. mutans; 90.0% growth inhibition at the MIC [A] > 90%Inhibition of E. coli and S. aureus by quaternized chitosan salts at 0.5 mg/mL [B] BiofilmFormation is significantly inhibited, with activity increasing as substitution degree rises [A/B]

How the permanent charge works [A]

  • Electrostatic binding to negatively charged cell envelopes.
  • Increased cell-wall permeability (alkaline phosphatase leakage).
  • Disrupted membrane integrity—visible pitting under SEM.
  • Inhibited respiratory metabolism and protein/DNA synthesis.

Gentle, film-forming antimicrobial support for leave-on systems. Position it as preservative-boosting support; actual in-formula performance must be confirmed by preservative challenge testing.

Sources: [A] Gao et al., Molecules 2024 (N-2-HACC against S. mutans; MIC/SEM/biofilm); [B] Wang et al., Int. J. Biol. Macromol. 2024 (chitosan quaternary ammonium salts; E. coli/S. aureus).

09 · SAFETY AND MILDNESS

Cationic performance without the baggage

ChitoQ carries its charge on a high-molecular-weight polysaccharide backbone—it stays on the surface where it works, rather than penetrating like a small-molecule quaternary ammonium salt.

No cytotoxicity in cell testing [A]

HACC-based derivatives showed no significant toxicity toward L929 fibroblasts; independent literature describes N-2-HACC as having very low toxicity and high safety.

Bio-based and biodegradable [A/C]

The marine-derived polysaccharide backbone addresses sustainability and environmental-persistence concerns associated with traditional synthetic cationic polymers.

Built-in antioxidant benefit [A]

Beyond conditioning, HACC derivatives show free-radical scavenging activity (DPPH and superoxide anion).

A high-molecular-weight cationic biopolymer designed for surface action. Finished-formula suitability and regulatory compliance remain the responsibility of the product developer; a complete toxicology dossier is available upon request.

Sources: Han et al., Int. J. Biol. Macromol. 2024 (L929 cytotoxicity and antioxidant assays); Gao et al., Molecules 2024; Processes 2026 review (limitations of cationic systems).

10 · HAIR + SCALP SYNERGY

One functional biopolymer—two cosmetic interfaces

Hair fibre

  • Targeted deposition [B]: cationic chains anchor to negatively charged damaged keratin sites.
  • Cuticle smoothing [C]: the adsorbed film lays raised cuticles flat and reduces inter-fibre friction.
  • Anti-static control [C]: charge neutralization tames static and humidity-induced frizz.
  • Protective conditioning layer [B]: the affinity polymer film helps protect hair from daily mechanical damage.

Scalp

  • Moisture management [B]: the humectant polysaccharide film helps retain water at the scalp surface.
  • Surface comfort film [C]: an ultra-thin polymer layer provides a smooth, protected skin feel.
  • Microenvironment support [A]: demonstrated antimicrobial activity supports scalp-care concepts.
  • Formulation support [A]: water-phase compatibility simplifies scalp lotions, essences, and cleansing formulas.

The charge-affinity mechanism that conditions hair also serves the skin where hair grows.

See the evidence section for grading. Sources: Gao et al., Molecules 2024 [A]; Mi et al., Polymers 2021 [B]; US 4,772,689 [B].

11 · PERFORMANCE ARCHITECTURE

One polymer, six cosmetic functions.

01 CONDITION | Affinity cationic deposition

Permanent charge anchors the polymer to hair keratin and skin surfaces for rinse-resistant conditioning. [B]

02 SMOOTH | Film-forming surface refinement

An ultra-thin adsorbed film smooths cuticles and skin microrelief, reducing friction and roughness. [C]

03 HYDRATE | Water retention and binding

The hydrophilic polysaccharide structure binds water, with moisturization benchmarked against hyaluronic acid. [B]

04 PROTECT | Polymer protective interface

The deposited layer buffers hair fibres and skin surfaces against mechanical and environmental stress. [C]

05 CONTROL | Anti-static and manageability

Charge neutralization reduces static and makes wet and dry combing easier. [C]

06 SUPPORT | Skin and scalp-care functions

Demonstrated antimicrobial and moisturizing activity extends care from hair fibres to scalp and skin. [A]

Molecule → mechanism → performance → formulation → consumer benefit

The functional portfolio is limited to scientifically supported roles; see the evidence section for grading.

12 · APPLICATION OPPORTUNITIES

One ingredient, two care categories

Hair and scalp

  • Conditioning shampoos—deposition without build-up; compatible with amphoteric surfactant systems.
  • Rinse-off conditioners and masks—wet-combing slip, cuticle sealing, and shine.
  • Leave-on anti-frizz serums/sprays—an anti-static film with humidity resistance.
  • Scalp lotions—moisturization plus microbial-balance support.
  • Color-care systems—film protection against wash-out and UV fading.

Face and body

  • Moisturizing serums/essences—hyaluronic-acid-level hydration with a perceptibly cushioned skin feel.
  • Moisturizers and barrier creams—a breathable film that slows water loss.
  • Sheet-mask essences—affinity hydration that lasts after mask removal.
  • Facial mists/toners—water-clear and non-tacky.
  • Gentle cleansers—a conditioned after-feel with a microbial-support story.

Every concept inherits the same trio: affinity deposition · moisturization · microbial support

Concept directions are provided for development reference only; prototype formulas are available from the Puripharm application laboratory.

13 · FORMULATION GUIDE

Born for the water phase

Parameter Guidance
INCI / form Chitosan Hydroxypropyltrimonium Chloride—off-white powder
Use level Varies by dosage form—the Puripharm application laboratory provides system-specific starting recommendations
Solubility Readily soluble in water across a broad pH window—no acidification required
Working pH Functional pH 3–10; comfortable formulation range pH 4–8
Addition Disperse in the water phase under moderate stirring until clear
Compatibility Cationic—avoid strongly anionic surfactants/polymers; best paired with nonionic and amphoteric systems
Process tolerance The polysaccharide backbone is stable; add below 80 °C to protect color and viscosity

Formulator notes

  • Rinse-off products: deposit first, rinse second—affinity withstands dilution.
  • Screen salts—high ionic strength compresses charge interactions.
  • Brings light, elegant viscosity to aqueous systems.
  • Pair with humectants (glycerin, betaine, PCA) to strengthen the hydration story.
  • Confirm preservative synergy in the final base through challenge testing.

Prototype formulas (conditioning shampoo, moisturizing serum, and scalp lotion) are available from the Puripharm application laboratory.

Guidance is based on published physicochemical behavior of quaternized chitosan and Puripharm application experience; validate in the final formula.

14 · DIFFERENTIATION

A bio-based answer to synthetic cationic polymers

Dimension PURIACTIVES® CHITOQ Native chitosan Synthetic polyquaterniums
Source Marine-derived, bio-based Marine-derived, bio-based Petrochemical
Charge vs pH Permanently cationic, pH 3–10 Only below pKa ≈ 6.5 Permanently cationic
Water compatibility Direct dissolution, no acidification Acidic media only Good
Affinity High—keratin and skin Moderate, pH-limited High
Multifunctionality Conditioning + moisturization + antimicrobial support Film-forming and moisturizing Conditioning only
End of life Biodegradable polysaccharide Biodegradable Persistence concern

Synthetic-grade performance with a biopolymer story—without naming any commercial competitor.

15 · QUALITY AND REGULATORY

Batch traceability—all 11 tests passed

Specification vs representative production batch

Test item Specification Batch result
Appearance Off-white powder Complies
Solubility Soluble in deionized water Complies
Moisture ≤ 10.0% 8.7%
Ash ≤ 1.0% 0.45%
pH (1% solution) 5.5–7.5 6.41
Viscosity (1% aqueous solution, 20 °C) Meets product claim 18 mPa·s
Degree of deacetylation ≥ 85.0% 89.2%
Degree of substitution ≥ 80.0% 98.5%
Arsenic (As) ≤ 4.0 mg/kg Not detected (< 0.01)
Lead (Pb) ≤ 2.0 mg/kg Not detected (< 0.02)
Water-insoluble matter ≤ 0.5% 0.03%
11 / 11All quality tests passed for the current production batch 98.5%Degree of substitution; specification ≥ 80% NDArsenic and lead below detection limits (< 0.01 / < 0.02 mg/kg)

Regulatory identity

The INCI name Chitosan Hydroxypropyltrimonium Chloride is listed in the EU CosIng database with hair-conditioning and humectant functions. Each batch is supplied with COA, TDS, and SDS.

Puripharm Co., Ltd. batch inspection report (May 2026); complete COA, TDS, and SDS are available upon request. EU CosIng listed functions: hair conditioning and humectant.

16 · SUMMARY

ChitoQ earns a place in your formula

Marine chitosan backbone → functional quaternization → water compatibility + permanent charge → biological surface binding → multifunctional performance

No more formulation compromise

Water compatibility across pH 3–10 ends the acidic-system constraint of native chitosan.

Performance that stays

Permanent cationic affinity delivers rinse-resistant conditioning and moisturization.

A cleaner label story

Bio-based, biodegradable, and clean in cell testing—a credible successor to synthetic polyquaterniums.

Honestly graded evidence

ChitoQ-specific data lead the story; related quaternized-chitosan and chitosan literature is clearly labeled.

One SKU, three functions

Conditioning, moisturization, and antimicrobial support simplify formulas and strengthen claims.

End-to-end support

Specifications, dossiers, and prototype formulas travel with the ingredient—not as an afterthought.

ChitoQ turns an exceptional biopolymer into a reliable formulation tool.

PURIPHARM CO., LTD.

Let’s build the next generation of care products together.

Request PuriActives® ChitoQ samples, specifications, safety dossiers, and prototype formulas.

Website www.puriactives.com
Email service@puripharm.com
Phone +86-572-2745768
Address Building 6, No. 1366 Hongfeng Road, Huzhou, Zhejiang, China

PuriActives® and ChitoQ® are registered trademarks of Puripharm Co., Ltd. This presentation introduces a cosmetic ingredient only and contains no drug claims. In vitro and third-party literature data are identified and do not represent clinical performance of finished products.

PuriActives® MEVAL 100L

SCIENTIFIC MARKETING PRESENTATION · ENGLISH

PuriActives®MEVAL 100L

Mevalonolactone 100LHigh-purity mevalonolactone enabled by synthetic biology

(R)-mevalonolactone · C6H10O3 · MW 130.14

A foundational metabolite of the mevalonate pathway, brought into modern skin and hair science through precision biotechnology.

High purityDefined, controlled composition High activityMevalonate pathway biology
Clean productionControlled biosynthesis Green biotechnologyResource-efficient platform

OPENING PERSPECTIVE

A new generation of metabolic actives is reshaping skin science

Cosmetic science is moving beyond conventional antioxidant and moisturizing concepts toward support for more fundamental biological processes: cellular energy, lipid synthesis, metabolic signaling, epidermal renewal, and barrier homeostasis.

Healthy skin depends not only on structural components, but also on the metabolic pathways that continuously build and maintain them.

Five core processes in metabolic skin scienceCellular energyLipid synthesisMetabolic signalingEpidermal renewalBarrier homeostasis

NARRATIVE MAP

Five questions, one complete storyline

01 Why is the mevalonate pathway essential to skin and hair biology?
02 Why is mevalonolactone scientifically compelling as a cosmetic active?
03 What evidence supports its biological relevance—from cells to human skin?
04 Why do high purity and synthetic-biology production matter to formulators?
05 What new product concepts can be built with PuriActives® MEVAL 100L?

Storyline: Biology (the mevalonate pathway in skin and hair) → Evidence (cells, 3D epidermis, human studies) → Scalp and hair → Platform (synthetic biology and purity) → Applications.

CHAPTER 01 · BIOLOGY

The mevalonate pathway: a central metabolic hub linking lipid synthesis, cellular signaling, and tissue homeostasis

It operates in both the epidermis and the hair follicle.

1.1 Skin care is shifting from surface correction to metabolic support

Healthy skin depends not only on structural components, but also on the metabolic pathways that continuously build and maintain them.

Traditional model Metabolic model
Supply finished materials from the outside:· Occlusive and humectant moisturization· Topical lipid supplementation· Antioxidant quenching· Surface exfoliationThese benefits are real, but often symptomatic and temporary. Support the pathways that generate skin lipids and signals:· De novo lipid biosynthesis· Lipid transport and secretion· Metabolic signaling (PPAR, ABCA12)· Epidermal renewal capacityThis approach targets the underlying mechanism of barrier homeostasis.

Where MEVAL 100L fits: mevalonolactone supplies substrate to the mevalonate pathway—the metabolic route through which every epidermal cell synthesizes cholesterol and isoprenoids.

1.2 Mevalonolactone: a stable, ready-to-use form of a foundational metaboliteode=”block” data-draft-type=”table” data-size=”normal” data-row-style=”normal”>

(R)-mevalonolactoneLactone form (R)-mevalonateOpen-chain form


aft-node=”block” data-draft-type=”table” data-size=”normal” data-row-style=”normal”>

(R)-mevalonolactoneLactone form (R)-mevalonateOpen-chain form

Reversible hydrolysis in aqueous environments

INCI / CAS Mevalonolactone / 674-26-0 (EC 211-615-0)
Formula / MW C6H10O3 / 130.14
Active configuration (R)-(–)-mevalonolactone, the naturally bioactive enantiomer
Regulatory identity EU CosIng (humectant); China IECIC 2021 (No. 03342)

Why the lactone form?

Mevalonolactone is the intramolecular δ-lactone of mevalonate; the two forms interconvert in water. The lactone is chemically stable and easier to formulate and store. Like a prodrug-like delivery form, it hydrolyzes in the aqueous environment of skin into the biologically active acid.

Isolated hepatocytes take up the lactone and channel it into sterol synthesis at least as efficiently as the free acid.

Sources: Chen B. et al., Skin Res Technol. 2022;28:804–814; Edwards P.A. et al., J Biol Chem. 1983;258:7272–7275; PubMed 901801.

1.3 One pathway supplies the lipids that maintain the barrier

  • HMG-CoA reductase: the rate-limiting step; inhibited by statins.
  • Mevalonate: the first committed product; can be supplied by mevalonolactone.
  • Squalene → cholesterol: a structural lipid of the stratum corneum barrier.
  • Coenzyme Q10: supports mitochondrial electron transport and antioxidant defense.
  • Dolichol: supports protein N-glycosylation in the endoplasmic reticulum.
  • Protein prenylation: anchors Ras/Rho-family signaling GTPases to membranes.

When pathway flux declines with age or stress, the supply of barrier lipids declines as well. Supporting the pathway supports the barrier.

1.4 Ceramides, cholesterol, and free fatty acids form the “mortar” of the barrier


  • Ceramides: the backbone of lamellar sheets.
  • Cholesterol: regulates lamellar fluidity and packing; its synthesis is required for barrier repair.
  • Free fatty acids: complete the crystalline lipid matrix that limits water loss.

Of these three, cholesterol supply depends directly on the mevalonate pathway.

1.5 Blocking the pathway impairs the barrier; adding mevalonate restores it

Condition Observation
ControlVehicle-treated mouse epidermis Normal lamellar body structure; barrier recovery follows the normal time course after disruption.
Pathway inhibitionTopical HMG-CoA reductase inhibitor Abnormal lamellar body morphology; delayed barrier recovery.
Inhibition + mevalonateCo-application of mevalonate or cholesterol Lamellar body structure normalizes and recovery is rescued. Cholesterol produces the same rescue effect.

Epidermal cholesterol synthesis is causally required for barrier repair—and mevalonate supplementation can reverse this deficit.

Source: Feingold et al., J Clin Invest, 1990;86(5):1738–1745. Topical lovastatin model in mouse epidermis.

1.6 Cholesterol synthesis falls in aged epidermis—and mevalonate helps restore it

  • Cholesterol synthesis in aged epidermis falls to about half the young level.
  • Topical cholesterol only partially restores synthesis.
  • Topical mevalonate restores synthesis close to the young level and improves barrier recovery.
  • The effect is age-dependent: young skin is not affected.

Supplying a pathway substrate outperforms supplying the end product.

CHAPTER 02 · EVIDENCE

From cells to skin: lipid synthesis, 3D epidermal models, and a randomized human study

This chapter also includes independent technical literature on fermentation-derived (R)-mevalonolactone.

2.1 Two complementary routes in keratinocytes

  • Route 1 | Substrate supply: supplies the mevalonate pathway downstream of the rate-limiting step, supporting cholesterol, isoprenoid, ceramide, and free fatty acid production.
  • Route 2 | Metabolic signaling: mevalonate-derived signaling increases PPARβ/δ expression (mRNA ~1.7-fold), followed by increased ABCA12 and lamellar bodies, enabling more lipid transport and secretion into the stratum corneum.
  • The effect disappears after PPARβ/δ knockdown by siRNA.

Mechanism established in cultured human keratinocytes: Chen et al., Skin Res Technol, 2022;28(6):804–814.

2.2 In vitro: free fatty acid output increases severalfold


Control — Nile Red staining + MVL — stronger lipid fluorescence

 

Control — Nile Red staining + MVL — stronger lipid fluorescence
  • Free fatty acids are one of the three major structural lipids of the barrier.
  • The largest increases occur in long-chain fatty acids—the same family of raw materials used to build ceramides.
  • Nile Red fluorescence visually confirms the lipid increase in the same model.

This pathway does more than synthesize cholesterol—it amplifies the broader lipid-synthesis program.

Fold changes: Chen et al., Skin Res Technol, 2022. Nile Red images: independent technical literature on fermentation-derived (R)-mevalonolactone, presented at the 132nd Annual Meeting of the Pharmaceutical Society of Japan.

2.3 3D epidermal model: TEWL falls to 27% of control

  • TEWL (transepidermal water loss) is a standard functional measure of barrier integrity.
  • A 73% reduction in a living, stratified epidermal model goes beyond what a single-cell assay can show.
  • The result connects cellular lipid data with tissue-level barrier performance.

From lipid biochemistry to a functional barrier—closed within the same model system.

2.4 Randomized human study: 0.1% MVL emulsion improves barrier and lipids

Sixty-six women in winter; randomized, vehicle-controlled; 0.1% mevalonolactone emulsion applied twice daily for 2 weeks (MVL n=30 and vehicle n=29 included in the analysis).

  • Winter conditions increased TEWL; the MVL group barely increased (+1.17), while the vehicle group increased markedly (+4.91).
  • Surface lipids increased in the MVL group (+3.50) and decreased with vehicle (−2.26), consistent with the in vitro lipid data.
  • Stratum corneum hydration improved significantly versus vehicle (p < 0.01). Together, the three measures indicate a stronger, better-supplied barrier.

The pathway-level mechanism observed in vitro translates into measurable benefits in human skin.

2.5 Independent split-face data: (R)-MVL is associated with visible wrinkle improvement

Independent technical literature on fermentation-derived (R)-mevalonolactone (not a PuriPharm study): randomized split-face trial, 24 women, 0.05% cream, 8 weeks.


Before use After 8 weeks

 

Before use After 8 weeks

Skin surface replicas (crow’s-feet area), SV600 analysis: finer and shallower texture after 8 weeks.

Additional data from the same literature

  • Water retention in a 3D epidermal model was approximately three times the control.
  • TEWL decreased from approximately 4.3 to 1.2 g/m²/h (n=9).

Source: independent technical literature on fermentation-derived (R)-mevalonolactone. Not a PuriPharm study; not measured data for MEVAL 100L.

2.6 Early signals beyond the barrier

Antioxidant network· The mevalonate pathway also builds the isoprenoid side chain of coenzyme Q10.· Patent literature proposes mevalonolactone to support epidermal CoQ10 and antioxidant defense.· Mechanistic rationale only; human data are not yet available. Microbiome and safety· MVL inhibits Staphylococcus epidermidis biofilm formation in vitro.· Relevant to the skin and scalp surface ecosystem.· Oral-intake studies report a favorable safety profile in models.

Directional early signals—development opportunities, not current product claims.

Sources: KR10-2018-0114391 A (melanin/tyrosinase); DE10148266 A1 (CoQ10 concept); Scopel et al., 2014, PMID 24111986; Yogev et al., PNAS, 2023;120(7):e2217831120.

2.7 Summary: one molecule, a five-step chain

Step Link Meaning
01 Pathway supply Mevalonate energizes lipid-synthesis pathways
02 Lipid output ↑ Cholesterol, free fatty acids, ceramide precursors
03 Barrier function ↑ TEWL falls in 3D epidermis and human skin
04 Hydration and lipids ↑ Human RCT: hydration and surface lipids increase
05 Firmness and texture Literature: improved elasticity and wrinkle appearance

Healthy aging means keeping the skin’s own production line running.MEVAL 100L supports the source—not just the surface.

CHAPTER 03 · SCALP AND HAIR

The same pathway: hair follicles and epidermis share a lipid supply line

The hair follicle is one of the most metabolically active structures in the human body.

3.1 Hair follicles and epidermis rely on the same cholesterol supply

What the literature shows

  • The follicular cholesterol-synthesis machinery is highly active. DHCR24, the terminal enzyme of cholesterol synthesis, is strongly expressed in hair follicles, and cholesterol is incorporated into the hair shaft during hair formation.
  • The pathway is downregulated in hair loss. HMGCR and HMGCS1—genes controlling mevalonate production—are downregulated in patients with alopecia.
  • Disrupting lipid signaling damages follicles. PPARγ deletion causes scarring alopecia in animal models.
  • Recent research links cholesterol to hair growth. A 2025 report connects cholesterol with sympathetic-nerve activation, hair-follicle stem-cell proliferation, and hair loss when synthesis is blocked.
ImplicationCholesterol supply in the follicle is active and essential—and compromised in hair loss. Rational entry pointA pathway-supporting active can supply the substrate used by the tissue’s own lipid-building machinery.

Sources: Palmer et al., 2020; Karnik et al., 2009; Nikhila et al., 2025; Guo et al., 2025. Follicle data are literature evidence, not measured results for MEVAL 100L.

3.2 Scalp care is becoming “skinified”—and the follicle is a metabolic organ

The scalp is skin· The scalp stratum corneum uses the same lipid triad: ceramides, cholesterol, and free fatty acids.· Barrier damage appears as dryness, tightness, and flaking—the most common scalp-care concerns.· A healthy scalp barrier is the foundation for all hair benefits. The follicle is a metabolic organ· Anagen follicles are among the most metabolically active tissues in the body.· Hair-shaft construction depends on cholesterol synthesis and lipid supply.· Pathway genes are downregulated in hair loss—supply matters.

MEVAL 100L uses one pathway for two targets: the scalp barrier above and follicle metabolism below.

CHAPTER 04 · PURIPHARM PLATFORM

Synthetic biology turns pathway insight into a manufacturable active

High purity, the correct enantiomer, clean production, and scalability.

4.1 Producing mevalonolactone in a nature-inspired way

Traditional chemical route PuriPharm route — fermentation
· Petrochemical feedstocks· Multi-step synthesis relying on protecting-group chemistry· Racemic product—50% (R), 50% inactive (S)· Solvent-intensive purification· Process waste at every step · Renewable feedstocks—sugars rather than petrochemicals· Engineered microorganisms run the full pathway in a single fermenter· Stereoselective—the biologically active (R)-enantiomer· Mild aqueous conditions—ambient temperature and pressure· Scalable—reported titers above 100 g/L in the literature

Literature and patent data; not specifications for MEVAL 100L.

4.2 Three disciplines, one value chain

01 Biology identifies the pathway.
02 Biotechnology manufactures the active.
03 Cosmetic science turns it into benefits.

This is the PuriPharm development model behind MEVAL 100L.

4.3 Only the (R)-enantiomer enters the pathway

  • Mevalonolactone has one stereocenter; the (R)-form is the natural form used by mevalonate kinase.
  • The (S)-form does not enter the pathway.
  • Half of a racemic mixture is an inactive “passenger.” Enantioselective fermentation removes it—every gram of MEVAL 100L is in the form skin can use.

4.4 Precision biology, cleaner chemistry

  • Renewable feedstocks: sugars replace petrochemical starting materials.
  • Mild aqueous fermentation: ambient temperature and pressure, without harsh reagents.
  • Fewer steps, less waste: one fermenter replaces a multi-step synthesis sequence.
  • A molecule biology already knows: the lactone hydrolyzes to mevalonate, a natural human metabolite.

Qualitative process attributes only; no quantitative sustainability claim is made. Life-cycle data are available upon request.

CHAPTER 05 · PRODUCT AND APPLICATIONS

MEVAL 100L: a clearly characterized molecule with nothing to hide

5.1 Product identity and recommended use level

INCI name Mevalonolactone
CAS / EC No. 674-26-0 / 211-615-0
Formula C6H10O3 · MW 130.14 g/mol · water-miscible lactone
Stereochemistry (R)-enantiomer—the bioactive form, produced by fermentation
CosIng function Humectant (EU CosIng database)
IECIC 2021 (China) Listed, No. 03342—historical maximum leave-on use level 0.05%
Recommended use 0.05–1%—based on published in vitro and human studies

Only publicly verifiable identity information is listed here; no specifications are invented. Full product specifications (appearance, purity, enantiomeric excess, microbial limits) are available from PuriPharm Co., Ltd.

5.2 One active, six skin-care directions (ranked by evidence strength)

Direction Evidence Product relevance
01 Barrier repair Human RCT Daily moisturizing and barrier creams. Supplies substrate for all three barrier lipids; TEWL benefits are validated in 3D epidermis and human skin.
02 Healthy aging and firming Technical literature Elasticity and wrinkle-appearance care. Independent split-face data for (R)-MVL show measurable improvement within 8 weeks.
03 Dry and sensitive skin Human RCT Winter protection and recovery. In the randomized study, hydration increased and surface lipids were preserved under winter stress.
04 Tone and radiance Exploratory Patent data show inhibition of melanin and tyrosinase in B-16 melanocytes. A development direction, not a claim.
05 Antioxidant support Exploratory The same pathway builds the side chain of coenzyme Q10, providing a mechanistic basis for pairing with antioxidant systems.
06 Microbiome-friendly care Exploratory In vitro inhibition of S. epidermidis biofilm suggests relevance to the surface ecosystem. Early signal only.

Directions 04–06 are supported only by patent-level or in vitro data; they represent development potential, not finished-product claims.

5.3 Scalp and hair: four entry points, one logic

01 Scalp barrier care|Skin evidence directly applicableLeave-on scalp tonics and serums for dry, tight, flaky scalps. The scalp stratum corneum uses the same lipid triad as facial skin—barrier evidence can be transferred directly.
02 Hair-growth support concept|ExploratoryThe follicular cholesterol machinery is active during anagen and downregulated in hair loss. Supplying pathway substrate is a rational—but still to be validated—growth-support strategy.
03 Aging-scalp care|Analogy to skin agingScalp skin ages like facial skin: lipid synthesis declines and the barrier weakens. The healthy-aging logic from Chapter 2 naturally extends to the scalp.
04 Microbiome-friendly scalp care|ExploratoryIn vitro biofilm inhibition points toward scalp-ecosystem applications—an early signal to be developed, not a claim.

Follicle-level evidence comes from pathway literature; product-level hair claims require dedicated studies. PuriPharm welcomes co-development projects.

5.4 Three skin-care concepts to start the co-development conversation

Concept A · Face | Metabolic barrier serum

0.1% MEVAL 100L combined with a ceramide–cholesterol–free fatty acid complex. Substrate plus building blocks: the serum replenishes finished lipids while feeding lipid synthesis.

Evidence anchor—human RCT: TEWL remained at +1.17 versus +4.91 with vehicle; hydration and surface lipids increased.

Concept B · Face/body | Winter repair cream

0.05–0.1% MEVAL 100L in a rich physiological-lipid base. Designed for seasonal barrier stress: dryness, tightness, and elevated TEWL in cold weather.

Evidence anchor—the randomized study was conducted in winter under real barrier stress.

Concept C · Face | Firming serum

0.05% MEVAL 100L paired with a peptide system. A metabolic view of firming: lipid supply improves skin quality while peptide signaling acts on the dermal matrix.

Evidence anchor—technical literature: elasticity R3 improved within 8 weeks (0.05% cream).

Concepts are illustrative starting points for co-development. Final claims must be validated in the finished formula; technical-literature anchors do not constitute measured data for MEVAL 100L.

5.5 Three scalp and hair concepts on the same platform

Concept A · Leave-on scalp | Scalp barrier tonic

0.05–0.1% MEVAL 100L in a lightweight water-based scalp tonic. Addresses dryness, tightness, and flaking at the source—the scalp’s own lipid supply.

Logic anchor—scalp barrier biology matches facial skin; skin RCT evidence can be transferred directly.

Concept B · Scalp serum | Anagen-support serum

0.1% MEVAL 100L in a follicle-directed leave-on serum. A metabolic concept for hair-density care: support the pathway on which anagen follicles depend.

Logic anchor—pathway genes are downregulated in hair loss (literature). Product-level validation is required.

Concept C · Scalp essence | Aging-scalp essence

0.05–0.1% MEVAL 100L paired with antioxidant ingredients. Extends the healthy-aging story to the scalp: lipid supply, barrier quality, and comfort.

Logic anchor—cholesterol data in aged skin (Haratake 2000) are relevant to scalp-skin aging.

Concepts are illustrative starting points for co-development. Hair-growth positioning is exploratory and requires dedicated product-level studies before any claim is made.

5.6 Formulating with MEVAL 100L: simple, compatible, literature-guided

Practical guidance Pairing logic
· Use level: 0.05–1%. Human data are concentrated at 0.05–0.1%; observe local limits (China IECIC: historical maximum leave-on use level 0.05%).· Water-miscible lactone. Can be added directly to aqueous systems and the water phase of emulsions.· Lactone ⇌ acid equilibrium. In water, MVL equilibrates with mevalonate—both are pathway-relevant; conventional skin-care pH is suitable.· Small, stable molecule. MW 130.14—no macromolecular handling constraints.· Compatible with physiological lipids. Designed to pair with ceramides, cholesterol, and fatty acids. + Physiological lipidsSubstrate + building blocks—a complete barrier concept+ HumectantsBarrier lipid supply + water retention—a moisturization concept+ Peptides / antioxidantsMetabolic support + signaling actives—a firming concept

General literature-guided recommendations, not a validated formula. PuriPharm technical service can provide starting formulations and stability support upon request.

CHAPTER 06 · COMMERCIAL VALUE

From science to market: the four-dimensional value framework of MEVAL 100L

01 DifferentiationA new mechanism story—metabolic support for the skin’s own lipid production, not another moisturizer or occlusive.
02 EvidenceA layered evidence package: human RCT, 3D epidermis, and keratinocyte mechanism—plus clearly labeled independent literature.
03 SupplyA fermentation platform: renewable feedstocks, (R)-selectivity, and scalability—consistent quality from batch to batch.
04 ComplianceEstablished INCI identity, CosIng function, and IECIC 2021 listing—a well-documented ingredient.

A differentiated story the marketing team can tell,and an evidence chain the regulatory team can defend.

Four market currents converge in one molecule

Barrier-first skin care Consumers increasingly see barrier health as the foundation of skin quality. MEVAL 100L goes directly to barrier biology—and is supported by human data.
Skin longevity and healthy aging The category is shifting from anti-aging correction toward maintaining the skin’s own production capacity—exactly the metabolic story of the mevalonate pathway.
Skinification of scalp care Scalp products increasingly borrow skin-care actives and language. MEVAL 100L brings scalp-relevant barrier and follicle logic.
Green biotech actives Brands are replacing petrochemical synthesis with fermentation. MEVAL 100L is made by synthetic biology: renewable feedstocks, (R)-selectivity, and clean production.

Positioning MEVAL 100L means standing at the intersection of these four currents.

Qualitative trend mapping only—no market-statistics claim is included.

Why MEVAL 100L: five reasons, one molecule

  1. A real mechanism—the mevalonate pathway is causally required for barrier repair.
  2. Human evidence—a randomized, vehicle-controlled study on real winter-stressed skin.
  3. The correct enantiomer—(R)-selective fermentation rather than a racemic compromise.
  4. Clean and scalable—synthetic-biology production based on renewable feedstocks.
  5. A dual platform—one active spanning skin care and scalp/hair care.

High purity · High activity · Clean production · Green biotechnology

REFERENCES AND DATA SOURCES

  1. Chen B, Lu N, Lee KS, Ye L, Hasegawa C, Maeda K. Application of mevalonolactone prevents deterioration of epidermal barrier function by accelerating the lamellar granule lipid transport system. Skin Res Technol. 2022;28(6):804–814. doi:10.1111/srt.13202.
  2. Feingold KR, Man MQ, Menon GK, Cho SS, Brown BE, Elias PM. Cholesterol synthesis is required for cutaneous barrier function in mice. J Clin Invest. 1990;86(5):1738–1745.
  3. Haratake A, Ikenaga K, Katoh N, Uchiwa H, Hirano S, Yasuno H. Topical mevalonic acid stimulates de novo cholesterol synthesis and epidermal permeability barrier homeostasis in aged mice. J Invest Dermatol. 2000;114(2):247–252. doi:10.1046/j.1523-1747.2000.00875.x.
  4. Feingold KR, Elias PM. Role of lipids in the formation and maintenance of the cutaneous permeability barrier. Biochim Biophys Acta. 2014;1841(3):280–294. doi:10.1016/j.bbalip.2013.11.007.
  5. Edwards PA, Lan SF, Tanaka RD, Fogelman AM. Mevalonolactone inhibits the rate of synthesis and enhances the rate of degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in rat hepatocytes. J Biol Chem. 1983;258(12):7272–7275.
  6. Scopel M, Abraham WR, Antunes AL, Henriques AT, Macedo AJ. Mevalonolactone: an inhibitor of Staphylococcus epidermidis adherence and biofilm formation. Med Chem. 2014;10(3):246–251. doi:10.2174/15734064113096660055.
  7. Yogev Y, Shorer Z, Koifman A, et al. Limb girdle muscular disease caused by HMGCR mutation and statin myopathy treatable with mevalonolactone. Proc Natl Acad Sci USA. 2023;120(7):e2217831120. doi:10.1073/pnas.2217831120.
  8. Palmer MA, Blakeborough L, Harries M, Haslam IS. Cholesterol homeostasis: links to hair follicle biology and hair disorders. Exp Dermatol. 2020;29(4):299–311. doi:10.1111/exd.13993.
  9. Karnik P, Tekeste Z, McCormick TS, Gilliam AC, Price VH, Cooper KD, Mirmirani P. Hair follicle stem cell-specific PPARγ deletion causes scarring alopecia. J Invest Dermatol. 2009;129(5):1243–1257.
  10. Panicker SP, Ganguly T, Consolo M, Price V, Mirmirani P, Honda K, Karnik P. Sterol intermediates of cholesterol biosynthesis inhibit hair growth and trigger an innate immune response in cicatricial alopecia. PLoS One. 2012;7(6):e38449. doi:10.1371/journal.pone.0038449.
  11. Nikhila L, Surya S, Najeeb SH, et al. Disrupted cholesterol biosynthesis and hair follicle stem cell impairment in the onset of alopecia. PLoS One. 2025;20(9):e0308455. doi:10.1371/journal.pone.0308455.
  12. Guo M, Jiang J, Zhang A, Yu W, Huang X. Cholesterol promotes hair growth through activating sympathetic nerves and enhancing the proliferation of hair follicle stem cells. Mol Med. 2025;31(1):86. doi:10.1186/s10020-025-01139-z.
  13. Yamashita M, et al. Mevalonolactone fermentation by Saccharomycopsis fibuligera. Fragrance Journal. 2000;28(2):62–65.
  14. Korean patent application KR10-2018-0114391 A (skin-brightening use of mevalonolactone); Korean patent KR101625898 B1 (fermentative production); German patent application DE10148266 A1 (CoQ10 support); international application WO2021041363 A1 (lipidomic effects).
  15. Independent technical literature on fermentation-derived (R)-mevalonolactone: split-face elasticity study (0.05% cream, 8 weeks, n=24) and Nile Red lipid data, 132nd Annual Meeting of the Pharmaceutical Society of Japan.

Data labeled as “technical literature” in this presentation were generated with fermentation-derived (R)-mevalonolactone—not MEVAL 100L—and are shown only as literature evidence.

Let’s build the next generation ofmetabolic actives together.

PuriPharm Co., Ltd.Building 6, No. 1366 Hongfeng Road, Huzhou, Zhejiang, China+86 572 2745768 · www.puriactives.com

PuriActives® MEVAL Mevalonolactone 100L — Product Presentation